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 Adiponectin in cattle: Profiling of the molecular weight patterns in different body fluids at dif-
ferent physiological states and assessment of adiponectin’s effects on lymphocytes 
 
Adiponectin (AdipoQ), one of the most abundant adipokines found in circulation exerts various meta-
bolic functions, e.g. improving insulin sensitivity and ameliorating tissue inflammation. It is secreted 
in different molecular weight (MW) forms: a low molecular weight (LMW) trimer, a middle molecular 
weight (MMW) hexamer and a high molecular weight (HMW) form which is built of 12 to 18 mono-
mers. Dairy cows undergo various metabolic changes in the time from late pregnancy to early lacta-
tion. This causes a mobilization of body reserves which may lead to a higher risk for infectious diseas-
es and possible problems in fertility later. The aims of this thesis were (1) to establish a semi-
quantitative Western blot to estimate AdipoQ concentrations in serum and milk of lactating dairy 
cows; (2) to develop a semi-native Western blot to differentiate AdipoQ MW patterns in several bo-
vine body fluids and tissues. (3) to estimate potential influences of AdipoQ on lymphocyte function; 
for this purpose AdipoQ was recombinantly expressed in Escherichia coli.  
First, the AdipoQ serum concentration in late pregnancy and the entire lactation as well as the concen-
trations in milk from d 1 to d 24 in lactation were estimated. Subsequently, a profile of the AdipoQ 
MW forms in serum and milk of dairy cows at different time points in lactation was generated. Fur-
thermore, the MW patterns of AdipoQ in two different adipose tissue (AT) depots (visceral and subcu-
taneous) at three different days (1, 42, and 105) after parturition were investigated. In addition the MW 
patterns of AdipoQ in the mammary gland were shown. The AdipoQ MW forms in cerebrospinal fluid 
(CSF) and corresponding serum of transition cows were characterized. Moreover the AdipoQ MW 
patterns in other Bovidae, i.e.Yak, Bison and Water buffalo were characterized. As body fluids in rela-
tion to reproduction we investigated the AdipoQ MW patterns in allantoic fluid (AF) and correspond-
ing maternal serum. In addition the AdipoQ concentrations and MW patterns in seminal plasma (SP) 
of bulls and follicular fluid (FF) of heifers were evaluated. Independent of the MW patterns, the func-
tional effect of recombinant AdipoQ on lymphocyte proliferation was studied.  
Adiponectin concentration in serum and milk showed an inverse course. Serum AdipoQ decreased 
until parturition and increased in early lactation, whereas AdipoQ concentration in milk was highest at 
the onset of lactation and decreased reaching a nadir in the first week of lactation. The changes in cir-
culating AdipoQ are probably related with the hormonal changes associated with parturition. The MW 
patterns of serum and milk showed a prominent MMW band and a faint HMW band. In contrast to the 
MW patterns observed in humans we speculate that the MMW form of AdipoQ might be the most 
abundant one in cattle; in Yak, Bison and Water buffalo, the MMW AdipoQ was also the most promi-
nent one. Different AT and mammary gland homogenates showed no differences in molecular weight 
pattern of AdipoQ. At each stage of lactation the HMW and the MMW band was detectable. CSF and 
serum samples of individual days in transition period showed no apparent differences in the MW pat-
tern of AdipoQ. The AdipoQ MW pattern in AF was different to the AdipoQ MW pattern seen in se-
rum before. AdipoQ was mainly detected as the HMW form, which might indicate that AF AdipoQ is 
not derived from circulation and might be of fetal origin. In bulls AdipoQ serum concentrations corre-
lated with the ones in SP and the MW distribution was mainly the same. AdipoQ MW pattern in FF of 
heifers was different to the serum MW pattern; The HMW band was virtually absent in FF independ-
ent of the stage of the estrous cycle. Recombinant AdipoQ reduced mitogen induced lymphocyte pro-
liferation which indicates that AdipoQ might be involved in the immune suppression. The results of 
this thesis provide AdipoQ profiles in several bovine body fluids. The physiological function of the 
individual AdipoQ isoforms needs to be further investigated.  
  
 Adiponektin beim Rind: Darstellung der Molekulargewichtsformen in unterschiedlichen Kör-
perflüssigkeiten in verschiedenen physiologischen Zuständen und Ermittlung des 
Adiponectineffekts auf Lymphozyten 
Adiponektin (AdipoQ) ist eines der am häufigsten in der Zirkulation vorkommenden Adipokine. Es 
beeinflusst verschiedene metabolische Prozesse und trägt zur Verbesserung der Insulinsensitiviät und 
der Eindämmung von Entzündungen im Gewebe bei. Die Sekretion erfolgt in drei unterschiedlichen 
Molekulargewichtsformen (MW): als Trimer in der niedermolekularen Form (low molecular weight, 
LMW), als Hexamer in der mittleren Molekularform (middle molecular weight, MMW), sowie als 
multimere hochmolekulare Form (high molecular weight, HMW), bestehend aus 12-18 Monomeren. 
Milchkühe sind in der Zeit der späten Trächtigkeit und frühen Laktation vielen metabolischen Verän-
derungen ausgesetzt. Die Mobilisierung von Körperreserven kann zu einem erhöhten Risiko für Infek-
tionskrankheiten führen und beeinflusst möglicherweise auch die spätere Fortpflanzungsleistung. Ziel 
dieser Arbeit war (1) die Etablierung eines semi-quantitativen Western Blots zur Bestimmung der 
AdipoQ-Konzentration in Serum und Milch von Milchkühen im geburtsnahen Zeitraum. Zusätzlich 
erfolgte (2) die Entwicklung eines semi-nativen Western Blots, um die unterschiedlichen MW von 
AdipoQ in verschiedenen Köperflüssigkeiten und Geweben zu charakterisieren. Desweiteren wurden 
(3) mögliche Auswirkungen von AdipoQ auf die Funktionsfähigkeit von Lymphozyten untersucht. 
Hierzu wurde AdipoQ rekombinant in Eschericha coli hergestellt. Im ersten Schritt wurde die Adi-
poQ-Konzentration in Serum von Milchkühen während der späten Trächtigkeit sowie im Verlauf der 
Laktation bestimmt, anschließend in Milch im Zeitraum vom 1. bis zum 24. Tag der Laktation. Im 
Anschluss erfolgte die Erstellung eines Molekulargewichtprofils in Serum und Milch von Milchkühen 
in der frühen und mittleren Laktation. Darüber hinaus wurden die MW von AdipoQ in zwei verschie-
denen Fettgeweben (adipose tissue, AT) (viszeral und subkutan) an Tag 1, 42 und 105 der Laktation, 
sowie in der Milchdrüse gezeigt. Weiterhin wurde das MW-Profil von AdipoQ in zerebrospinaler 
Flüssigkeit (cerebrospinal fluid, CSF) und korrespondierendem Serum von Milchkühen im 
peripartalen Zeitraum untersucht. In einem weiteren Schritt erfolgte die Ermittlung der AdipoQ-
Konzentration und des MW-Profils in Serum und Reproduktionsflüssigkeiten von Rindern; 
Seminalflüssigkeit (seminal plasma, SP) von Bullen, sowie Follikelflüssigkeit (folicular fluid, FF) und 
Fruchtwasser (alantois fluid, AF) von Färsen. Überdies konnten die MW von AdipoQ auch in artver-
wandten Spezies der Rinder (Yak, Bison, Wasserbüffel) dargestellt werden. Unabhängig vom MW 
wurden die Auswirkungen von AdipoQ auf die Proliferation von Lymphozyten bestimmt. Die Serum- 
und Milch-AdipoQ-Konzentrationen verliefen gegenläufig, im Serum sank die Konzentrationen bis 
zur Geburt und stieg danach wieder an. In Milch sank die AdipoQ-Konzentration im Verlauf der ers-
ten Laktationswoche wieder. Die Veränderungen der AdipoQ Konzentrationen stehen vermutlich in 
Verbindung mit den hormonellen Veränderungen im geburtsnahen Zeitraum.  
Das Profil der AdipoQ-MW in Serum und Milch zeigte eine prominente MMW-Bande und eine feine 
HMW Bande. Anders als beim Menschen könnte beim Rind die MMW die vorherrschende AdipoQ-
Form darstellen. Auch in Yak, Bison und Wasserbüffel war die MMW die prominenteste Bande. In 
den verschiedenen AT und der Milchdrüse konnte kein Unterschied im AdipoQ-MW bestimmt wer-
den. Zu jedem Zeitpunkt in der Laktation konnte eine MMW und eine HMW Bande detektiert werden. 
CSF und Serum von unterschiedlichen Zeitpunkten in der Übergangsphase zeigten keinen Unterschied 
in den MW von AdipoQ. In AF konnte nur eine HMW-Bande nachgewiesen werden nicht wie im 
Serum, was dafür spricht, dass AF-AdipoQ nicht aus der Zirkulation kommt und möglicherweise föta-
len Ursprungs ist. In Bullen korrelierte die AdipoQ-Serumkonzentration mit der im SP und auch die 
MW-Formen waren sich ähnlich. Die MW-Verteilung in FF und Serum war unterschiedlich, in FF war 
nur die MMW Bande zu finden, unabhängig vom Zeitpunkt im Zyklus. Rekombinant produziertes 
AdipoQ war in der Lage die Lymphozyten-proliferation zu senken, was darauf hindeuten könnte, dass 
AdipoQ Einfluss auf eine Immunsuppression haben könnte. Die Ergebnisse dieser Dissertation geben 
einen Überblick über die AdipoQ MW-Profile in unterschiedlichen bovinen Körperflüssigkeiten und 
Geweben.  
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CHAPTER I: General introduction  
 
1. Introduction 
 
Cattle are used for milk and meat production and contribute greatly to the human food supply. 
The use of high-yielding dairy breeds such as Holstein-Friesians has resulted in an increase in 
milk production during the past 50 years. Dairy cows have been selected to produce ~55 kg 
milk per day, which is three times the milk yield of dairy cows 30 to 40 years ago (Breves, 
2007). However, milk production exposes animals to a variety of stressors. Dairy cattle are 
susceptible to an increased incidence and severity of diseases during the periparturient period, 
which is the time from late pregnancy to early lactation (Sordillo et al., 2009). After parturi-
tion, milk production increases rapidly and body reserves are mobilized to cover the energy 
lost with milk. Consequently, the cow drifts into a negative energy balance (NEB). Energy 
balance is defined as the ratio between the energy consumed and the energy required for 
maintenance, growth, pregnancy and lactation (Grummer, 2007). Metabolic adaptations to 
NEB include increased hepatic gluconeogenesis and the increased mobilization of fatty acids 
from adipose tissue (AT) and amino acids from muscle (Bell, 1995). Many other bodily func-
tions are related to energy balance, e.g. the postpartum ovarian activity depends on the energy 
balance of the cow (Beam and Butler, 1999). Over-nutrition has been found to reduce placen-
tal-fetal blood flow and thus fetal growth in sheep (Wallace et al., 2002). Promoting optimal 
nutrition will therefore not only ensure optimal fetal development, but will also reduce the 
risk of chronic diseases in later life (Wu et al., 2004). Generally, AT not only serves as an 
energy store, it is also an endocrine organ; AT secretes hormones named adipokines. This 
term is restricted to proteins secreted from adipocytes, and excludes signals that are released 
only by other cell types (such as macrophages) in the AT (Trayhurn and Wood, 2004). 
Adipokines can act locally within the AT, but they can also reach distant organs through the 
blood circulation. In their target organs, adipokines can exert a wide range of biological ac-
tions. They are involved in lipid metabolism, insulin sensitivity, the alternative complement 
system, vascular homeostasis, blood pressure regulation and angiogenesis. In addition, there is 
a growing list of adipokines that are involved in inflammation and the acute-phase response 
(Trayhurn and Wood, 2004). One of the most abundant adipokines in the circulation is 
adiponectin (AdipoQ). Adiponectin in negatively correlated with body fat content and is 
known to be a key regulator of insulin sensitivity and tissue inflammation (Whitehead et al., 
2006).  
2   CHAPTER I: General introduction 
 
Adiponectin has been studied intensively in humans and rodents, whereas research about bo-
vine AdipoQ has been impeded by the lack of valid, species-specific assays. Adiponectin oc-
curs in a number of different molecular weight (MW) forms that are assumed to be of differ-
ent biological importance. Therefore, this thesis is focused on establishing Western blot 
methods to characterize AdipoQ MW forms in different body fluids at different physiological 
stages of cattle.  
 
2. Literature review 
 
2.1. The adipokine adiponectin  
 
Adiponectin is one of the most abundant adipokines found in the circulation, with concentra-
tions of around 0.01% of total serum proteins. Adiponectin was first described in the 1990s in 
mouse and human plasma (Scherer et al., 1995; Nakano et al., 1996). Sato et al. (2001) first 
isolated bovine AdipoQ. It is primarily secreted by adipocytes (Arita et al., 1999) and plays 
important roles in the regulation of glucose and lipid metabolism (Waki et al., 2003). Contrary 
to other adipokines produced by AT, e.g. Leptin and Visfatin, AdipoQ is inversely correlated 
with body mass and insulin resistance (Arita et al., 1999). High concentrations of AdipoQ 
lead to decreased gluconeogenesis and reduced intracellular triglyceride content in the liver, 
whereas glucose uptake in skeletal muscle is stimulated by AdipoQ (Waki et al., 2003). Fur-
thermore, AdipoQ exerts immunological functions; it regulates the expression of several pro- 
and anti-inflammatory cytokines. Its main anti-inflammatory function is potentially related to 
its capacity to suppress the synthesis of tumor-necrosis factor α (TNFα) and interferon-γ 
(IFNγ). Moreover, it is able to induce anti-inflammatory cytokines such as interleukin-10 (IL-
10) (Tilg and Moschen, 2006).  
 
2.1.1. Adiponectin structure and expression 
 
Bovine AdipoQ is a polypeptide of 240 amino acids which structurally belongs to the com-
plement factor 1q family (Sato et al., 2001). The amino acid sequence of bovine AdipoQ 
shows 92% homology with human AdipoQ and 82% homology with murine AdipoQ (Sato et 
al., 2001). Generally, the primary amino acid sequences of AdipoQ are highly conserved 
across species; sharing over 80% identity among all of the species cloned so far (Wang et al., 
2008). Adiponectin consists of different structural domains (Fig. 1); it has a secretory signal 
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sequence at the N-terminal part (amino acids 1–17), a variable region, which is the species-
specific region (Waki et al., 2003), a collagenous region (amino acids 45–111) and a globular 
domain (amino acids 112– 240) (Sato et al., 2001).  
 
 
Fig.1: Structural domains of bovine adiponectin. Numbers indicate the first amino acid of the corre-
sponding domain (modified according to Wang et al., 2008) 
 
Adiponectin is modified extensively at the post-translational level during secretion from adi-
pocytes. The amino acid residues of AdipoQ with known post-translational modifications are 
highly conserved among different species (Wang et al., 2008). Adiponectin is synthesized as a 
single 28 kDa monomer which undergoes multimerization to form multimers of different mo-
lecular weight (MW) forms prior to secretion (Fig. 2) (Waki et al., 2003). Low molecular 
weight (LMW) AdipoQ is composed of three monomers (combining to form a trimer) result-
ing in a size of 67 kDa. A hexamer formed by two trimers represents the middle molecular 
weight (MMW) form of AdipoQ with a size of 136 kDa. The high molecular weight (HMW) 
multimers of AdipoQ are comprised of 12 to 18 monomers and reaches a MW of more than 
300 kDa (Waki et al., 2003).  
In humans and mice, the HMW AdipoQ is the most abundant form circulating in the serum 
(Pajvani et al., 2003; Tsao et al., 2003). All modifications in MW are due to post-translational 
modifications like hydroxylation and glycosylation (Wang et al., 2004). Thereby, the con-
served proline and lysine residues in the collagenous domain are hydroxylated and afterwards 
glycosylated. The characteristic oligomeric isoforms are created by disulfide bonds at the cys-
teine in the variable region (Waki et al., 2003). 
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Fig. 2: Multimerization of adiponectin. LMW = low molecular weight, MMW = middle molecular 
weight, HMW = high molecular weight, and S-S = disulfide bonds (modified from Simpson and 
Whithead 2010) 
 
 
2.1.2. Adiponectin receptors and signaling  
 
Adiponectin has three receptors that are found in different tissues: adiponectin receptor 1 
(AdipoR1) and 2 (AdipoR2) (Yamauchi et al., 2003) and the cell surface protein T-cadherin 
(Hug, 2004). T-cadherin is believed to be one of the AdipoQ binding proteins because of its 
missing intracellular domain and its lack of expression in hepatocytes (Kadowaki et al., 
2006). AdipoR1 and AdipoR2 belong to the seven transmembrane receptor family; they have 
an intracellular amino terminus and an extracellular carboxyl terminus. AdipoQ signaling is 
mediated by several transcription factors and intracellular receptors (Fig. 3). Free AdipoQ 
binds to the N-terminal extracellular domain, whereas the intracellular C terminal domain 
binds to APPL1 (an adaptor protein containing a pleckstrin homology domain, a 
phosphotyrosine binding domain and a leucine zipper motif) (Mao et al., 2006; Cheng et al., 
2007; Thundyil et al., 2012). APPL1 acts as a link between the receptors and their signaling 
molecules. The signaling molecules activated by AdipoQ include adenosine monophosphate-
activated protein kinase (AMPK), mitogen-activated protein kinase (p38-MAPK), and peroxi-
some proliferator activated receptor α (PPARα) (Thundyil et al., 2012). Adiponectin signaling 
is down regulated by AMPK. Activation of AMPK by AdipoQ leads to decreased gluconeo-
genesis in the liver (Kadowaki and Yamauchi, 2005). The activation of PPARα by AdipoQ 
increases fatty acid oxidation in liver and muscle, and p38-MAPK activation by AdipoQ 
causes glucose uptake in muscle (Kadowaki and Yamauchi, 2005). 
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AdipoR1 mainly acts via the AMPK pathway, whereas AdipoR2 acts through the PPARα 
pathway (Yamauchi et al., 2007). Furthermore, it was shown that the AdipoQ receptors bind 
different MW forms of AdipoQ: AdipoR1 has a strong affinity for globular and full length 
AdipoQ, while AdipoR2 has an intermediate affinity for full-length and globular adiponectin 
(Whitehead et al., 2006). 
 
Fig. 3: Adiponectin receptors and signaling. AdipoR1/R2 = adiponectin receptor 1 and 2, APPL1 = 
adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine 
zipper motif, AMPK = adenosine monophosphate-activated protein kinase, PPARα = peroxisome pro-
liferator activated receptor α, p38-MAPK = mitogen-activated protein kinase, LMW = low molecular 
weight, MMW = middle molecular weight, HMW = high molecular weight, and S-S = disulfide bonds 
(modified from Thundyil et al., 2012) 
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2.2. Importance of adiponectin in cattle 
 
2.2.1. The transition period  
 
The transition period starts three weeks ante partum (a.p.) and ends three weeks post partum 
(p.p.). It is the most critical phase of the lactation cycle for dairy cows (Grummer, 1995). This 
time determines the profitability of dairy cows, because the ability to reach maximal produc-
tion efficiency can be impeded by health problems, nutrient deficiency or poor management 
(Drackley, 1999). During this periparturient period, the energy requirements of dairy cows 
increase; to cover the output of energy via milk, cows start to mobilize body fat and muscle 
tissue. The rapidly increasing demands of glucose, amino acids and fatty acids for milk pro-
duction cannot be sufficiently compensated for by feed intake alone. The reduction of dry 
matter intake around parturition is caused by alterations related to metabolic, physical, behav-
ioral and hormonal changes (Allen et al., 2005). Consequently, the cows enter a state of nega-
tive energy balance (NEB). To direct glucose towards the mammary gland, the insulin sensi-
tivity of peripheral tissues, e.g. muscle and adipose tissue (AT), is reduced (Bell, 1995). With 
low insulin concentrations in the serum and reduced insulin sensitivity, lipolysis in AT starts, 
which leads to an increase in serum concentrations of non-esterified fatty acids (NEFA) 
(Drackley et al., 2005). The uptake of NEFA into the liver during excessive lipolysis results in 
a risk of the development of fatty liver and possible negative effects on neutrophil function 
(Scalia et al., 2006). The circulating concentrations of β-hydroxybutyrate (BHB) are associat-
ed with the oxidation of fatty acids in the liver: BHB increases with the incomplete oxidation 
of fatty acids in the liver (Leblanc, 2010). Elevated BHB and NEFA concentrations lead to a 
higher incidence of ketosis and may also result in infectious diseases in like mastitis and 
metritis due to compromised immune function (Drackley, 1999).  
The role of AdipoQ in dairy cows is of special interest in the transition period because of its 
insulin-sensitizing effect (Whitehead et al., 2006). In dairy cows, the abundance of AdipoR1 
and AdipoR2 mRNA in subcutaneous adipose tissue was significantly different when compar-
ing a.p. and p.p. (Lemor et al., 2009). Adiponectin mRNA abundance increased in visceral 
(v.s.) AT with increasing days in milk (Saremi et al., 2014), but no information about the 
course of AdipoQ protein concentrations and the MW forms in the transition period was 
available until now.  
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2.2.2. Immune status of cows during the transition period  
 
Periparturient inflammatory diseases, like mastitis or puerperal fever, occur within the first 
two weeks after calving (Ohtsuka et al., 2004). Complex relationships between immune func-
tion and metabolic status exist. Impaired leukocyte function contributes to the susceptibility 
for infectious diseases in the periparturient period (Harp et al., 1991; Detilleux et al., 1995). 
The concentration of neutrophils, lymphocytes and monocytes varies from eight weeks a.p. to 
eight weeks p.p. With the exception of monocytes, all blood immune cells are increased one 
to two weeks prior to parturition, while these cell populations are lowest at parturition and in 
the first week p.p. (Meglia et al., 2005). Lymphocyte number decreases until parturition, 
mainly due to reduced lymphocyte proliferation (Kehrli et al., 1989). Furthermore, bovine 
blood lymphocytes are less responsive to mitogen stimulation, e.g. concanavalin A (ConA) 
(Nonneke et al., 2003). The proliferative activity of ConA-stimulated bovine peripheral blood 
mononuclear cells (PMBC), lymphocytes, monocytes and macrophages is reduced p.p. in 
comparison to the proliferative ability of PBMCs in mid-lactating cows (Shafer-Weaver and 
Sordillo, 1997).  
The major function of neutrophils is the elimination of infiltrated bacteria, mainly by phago-
cytosis. The functionality of neutrophils seems to be associated with NEB in the dairy cow 
(LeBlanc, 2012). Neutrophil phagocytosis and oxidative burst were increased during in vitro 
experiments in which they were incubated with early p.p. serum, reflecting the physiological-
ly high NEFA concentrations found in serum at parturition (Ster et al., 2012). Scalia et al. 
(2006) observed no effects for moderate concentrations of NEFA, but reported an increase in 
phagocytosis-induced oxidative burst at high concentrations (> 1mM). Additionally, the 
PBMC proliferation from mid-lactating cows is known to be negatively affected by incuba-
tion with the serum of early lactating cows, which naturally contains higher NEFA concentra-
tions compared to those seen mid-lactation. The impaired immune function might be more 
related to the serum composition at the beginning of lactation than to a defect of the immune 
cells (Ster et al., 2012). The increase of plasma NEFA is likely to exert negative effects on 
lymphocyte functions in cows (Lacetera et al., 2004). With increasing NEFA concentrations 
in the culture medium, PBMC reduce proliferation and the secretion of cytokines, e.g. IFNγ. 
Furthermore, the secretion of immune globulin M (IgM), which is an indicator of acute in-
flammation, is reduced (Lacetera et al., 2004). 
The potential effects of AdipoQ on immune cell function are mainly studied in human cell 
cultures.  
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Expression of AdipoQ and its receptors was shown in human bone marrow mononuclear cells 
(Crawford et al., 2010) and AdipoR1 was found to be expressed in human T-lymphocytes 
(Takahashi et al., 2010). Furthermore, low expression of the AdipoQ protein in lymphocytes 
has also been observed (Crawford et al., 2010). Adiponectin provides the ability to decrease 
the secretion of TNFα and IFNγ in human T-lymphocytes (Takahashi et al., 2010). The in-
duced secretion of TNFα and IL-6 of porcine macrophages by lipopolysaccharides (LPS), part 
of the cell membrane of gram-negative bacteria, is reduced by pre-incubation of these cells 
with AdipoQ. This suggests that the anti-inflammatory actions of AdipoQ include suppression 
of pro-inflammatory cytokines, e.g. IL-6, and the induction of anti-inflammatory ones, e.g. 
IL-10 (Wulster-Radcliffe et al., 2004).  
 
 
2.2.1.2. Adiponectin in reproduction 
 
Reproductive success is closely linked to energy balance, whilst metabolic dysregulation is 
linked with reproductive abnormalities (Schneider, 2004). The length of the p.p. anovulatory 
period is strongly associated with NEB through a decrease of luteinizing hormone (LH) pulse 
frequency and low levels of blood glucose and insulin, which collectively limit estrogen pro-
duction by dominant follicles (Butler, 2003). Lower fertility in dairy cows is related to NEB 
as a result of the effects that are exerted early in lactation and later during the breeding period 
(Butler, 2003). Energy homeostasis is regulated by AdipoQ through the modulation of glu-
cose and fatty acid metabolism in peripheral tissues (Dridi and Taouis, 2009). Adiponectin 
and its receptors are expressed in several tissues besides adipose and liver tissue (Table 1). 
The expression of AdipoQ mRNA was found in several tissues related to reproduction: rat 
pituitary gland (Rodriguez- Pacheco et al., 2007), chicken testis (Ocon-Grove et al., 2008), 
bull spermatozoa (Kasimanikman et al., 2013), human placenta (Caminos et al., 2005), and 
ovary (Chabrolle et al., 2007). Additionally AdipoQ mRNA was demonstrated in human lym-
phocytes (Crawford et al., 2010). The expression of AdipoR1 and R2 in the human pituitary 
gland suggests a feedback of the gonadotropic axis by AdipoQ (Psilopanagioti et al., 2009). In 
addition, AdipoQ is involved in the regulation of pituitary hormone secretion: it reduces the 
GnRH-stimulated LH secretion through the increased phosphorylation of AMPK (Lu et al., 
2008). The influence of AdipoQ on LH secretion in the pituitary gland was confirmed in cul-
tured rat pituitary cells (Rodriguez-Pacheco et al., 2007).  
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Recently, the mRNA and protein expression of AdipoR1 and R2 was shown in the porcine 
pituitary gland. Kiezun et al. (2013) showed that the expression of AdipoQ receptor mRNA 
and protein expression is affected by the stage of the estrus cycle in sows. The presence of 
both ligand and receptors in the porcine pituitary may suggest an auto-/paracrine role for 
AdipoQ in the regulation of the function of this gland (Kiezun et al., 2013). In particular, the 
expression of AdipoR2 differs throughout the estrus cycle; the highest expression of AdipoR2 
was found during the luteal phase, which might be related to increasing steroid hormone con-
centrations (Kiezun et al., 2013). 
Adiponectin is discussed as a potential marker for fertility. The expression of AdipoQ and its 
receptor mRNA and protein was shown in the bovine female reproductive system. The physi-
ological status of the ovary has significant effects on the natural expression patterns of 
AdipoQ and its receptors in follicular and luteal cells of the bovine ovary (Tabandeh et al., 
2010). The expression of AdipoQ mRNA in bovine granulosa cells of follicles (11-22 mm) is 
positively correlated with estradiol concentration in follicular fluid (Tabandeh et al., 2010). 
With increasing follicular size, the expression of AdipoQ and AdipoQ receptor mRNA in-
creases in bovine follicles, especially in cumulus and granulosa cells (Tabandeh et al., 2010). 
Adiponectin further decreases insulin-induced steroidogenesis in cultured bovine granulosa 
cells (Maillard et al., 2010). A positive correlation between serum and follicular fluid (FF) 
AdipoQ concentrations has been shown in women. Moreover, the AdipoQ concentration in 
FF was shown to be about five times lower than in serum (Bersinger et al., 2006). Beside the-
se differences in AdipoQ concentrations, the isoforms of AdipoQ also differ between serum 
and FF in women: in FF, the LMW (trimer) AdipoQ is the most abundant MW form, whereas 
in serum, the HMW is the major AdipoQ MW form (Bersinger et al., 2010).  
 
  
10   CHAPTER I: General introduction 
 
Table 1: Expression of Adiponectin (AdipoQ) and its receptors in several tissues  
 
Tissue/ 
cells Species 
AdipoQ AdipoR1 AdipoR2 
Reference 
mRNA Protein mRNA Protein mRNA Protein 
Pituitary 
gland 
human   +  +  
Psilopanagio
ti et al., 2009 
rat +  +  +  
Rodriguez-
Pacheco et 
al., 2007 
porcine  + + + + + 
Lu et al., 
2008 
 
Follicular 
cells 
bovine + + + + + + 
Tabandeh et 
al., 2010 
Maillard et 
al., 2010 
Luteal cells bovine +  +  +  
Tabandeh et 
al., 2010 
Ovary  bovine + + + + + + 
Tabandeh et 
al., 2010 
Maillard et 
al., 2010 
Testis 
rat 
chicken 
+ 
+ 
+ 
+ 
    
Caminos et 
al., 2008 
Ocon-Gove 
et al., 2008 
Fetal tis-
sue: skin, 
skeletal 
muscle, gut 
human + + 
    
Corbetta et 
al., 2005 
Amniotic 
membrane 
human + +     
Corbetta et 
al., 2005 
Placenta human  +     
Corbetta et 
al., 2005 
Mammary 
gland 
bovine +  +  +  
Saremi et al., 
2014 
T-
lymphocyte 
human   +    
Takahashi et 
al., 2010 
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2.2.4. Physiological regulation of milk production  
 
Milk production is mainly controlled by the hormones prolactin and growth hormone (GH). 
These hormones are essential for the transition from a proliferating to a lactating mammary 
gland (Svennersten-Sjaunja and Olsson, 2005). Growth hormone is the dominating hormone 
in ruminants (Flint and Knight, 1997); it increases the blood flow in mammary glands and has 
blood glucose-elevating effects. Prolactin increases the intestinal uptake of calcium and the 
uptake of fatty acids into the udder, which are necessary for milk fat synthesis (Svennersten-
Sjaunja and Olsson 2005). The elements that are necessary for milk synthesis are provided by 
the circulation; therefore, the blood flow through the mammary gland increases with decreas-
ing days until parturition. In sheep, blood flow in the mammary gland increases at parturition, 
whilst milk yield is correlated with mammary blood flow until peak lactation is reached (Niel-
sen et al., 1990).  
The main components of milk secreted by the mammary gland are fat, protein, and minerals. 
The composition of milk is dependent on the stage of lactation, breed, parity and the energy 
status of the cow (Grieve et al., 1986). In relation to milk yield, the components of milk vary 
during the lactation period. While lactose decreases during the course of lactation, fat and 
protein concentrations in milk increase after an initial decline.  
Adiponectin, as the insulin-sensitizing hormone with glucose-lowering effects (Yamauchi et 
al., 2003), is present in human milk. The concentrations range from 4 to 88 ng/mL (Newburg 
et al., 2010), depending on maternal nutritional status and diet during pregnancy. The concen-
tration of AdipoQ in milk is lower compared than that reported in the serum. In human milk, 
AdipoQ was suggested to play a role in the early growth and development of breast-fed in-
fants (Woo et al., 2009). Maternal AdipoQ milk concentrations are negatively correlated with 
the infant’s weight at birth and in the first two months. The MW form of AdipoQ found in 
human milk is predominantly HMW (Woo et al., 2009). Different results concerning milk 
AdipoQ concentrations throughout the course of lactation are available. Martin et al. (2006) 
showed a decrease of up to 6% in human milk AdipoQ concentrations with each month of 
lactation. They further mentioned that AdipoQ in milk increases in the period after parturition 
with increasing maternal post-pregnancy body mass index (Martin et al., 2006). Differing 
results concerning the AdipoQ concentrations in human milk over the lactation period have 
been described. Decreasing milk AdipoQ concentrations in the first 6 months of lactation 
were shown by Woo et al. (2009).  
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In an additional human study, significantly higher milk AdipoQ concentrations in the first 
week of lactation were observed compared to mature milk in the third month of lactation (Ley 
et al., 2012). In contrast to the above-mentioned results, the lowest AdipoQ concentrations 
(13.3 ± 0.6 ng/mL) were reported in human colostrum (day 1-3 p.p.), followed by an increase 
in milk AdipoQ concentration up to 180 days of lactation (Ozarda et al., 2012). 
 
2.2.5. Ontogenesis of adiponectin secretion  
 
The findings in human studies have led to the assumption that AdipoQ might be involved in 
fetal development. One indication for this is that the expression of AdipoQ mRNA and pro-
tein in fetal skin, skeletal muscle, gut and amniotic membrane, is at apparently lower levels 
than those expressed in adult white AT (Corbetta et al., 2005). Adiponectin in amniotic fluid 
is supposed to be of fetal origin, because of the lack of correlation with maternal serum 
AdipoQ concentrations (Baviera et al., 2007). Moreover, AdipoQ seems to be associated with 
early neonatal growth in humans. It was shown that cord blood AdipoQ concentrations in 
term-born neonates were higher than serum concentrations in adults (Arita et al., 1999; Inami 
et al., 2007). Positive correlations for AdipoQ cord blood concentrations with birth length and 
birth weight were described. Adiponectin might exert its influence on fetal growth, which is 
controlled by insulin and IGFs, by acting as an insulin sensitizer (Inami et al., 2007). When 
present in human cord blood, AdipoQ is associated with a slower weight gain in the first six 
months of life and not related to adiposity in three years of age (Mantzoros et al., 2009).  
At birth and at one month of age, no differences in serum AdipoQ concentrations were found 
between male and female infants (Inami et al., 2007; Kamoda et al., 2004). In contrast, a sex-
ual dimorphism of serum AdipoQ concentrations was described in adult humans and rodents; 
AdipoQ concentrations are lower in male than in female rats, mice and humans (Combs et al., 
2003; Pajvani et al., 2003; Arita et al., 1999). With increasing age, the serum concentrations 
of AdipoQ in rats increased independently of sex (Combs et al., 2002 and 2003). An increase 
in serum AdipoQ concentrations with age (18-78 years) was also observed in humans 
(Schautz et al., 2012).  
Besides the possible influences of AdipoQ on growing individuals, it also appears to be in-
volved in reproductive processes. Adiponectin in female reproduction is described in 2.2.1.2. 
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The contribution of AdipoQ to male reproduction was shown in human and rodent studies. 
Adiponectin mRNA and protein expression was found in rat and chicken testis (Table 1) 
(Caminos et al., 2008; Pfaehler et al., 2012; Ocon-Gove et al., 2008). Particularly in the tes-
tosterone-secreting leydig cells of rat and chicken testis, AdipoQ mRNA and protein were 
localized (Caminos et al., 2008; Ocon-Gove et al., 2008).  
AdipoQ concentrations in rodents are influenced by androgens; serum testosterone concentra-
tions are negatively correlated with serum AdipoQ concentrations in humans and rats (Page et 
al., 2005; Nishizawa et al., 2002). Moreover, orchidectomy or ovarectomy in rats leads to 
increased AdipoQ serum concentrations. Additionally, testosterone treatment of castrated 
male rats resulted in decreasing serum AdipoQ concentrations (Yarrow et al., 2012). Also, 
recombinant AdipoQ significantly inhibited basal and human choriogonadotropin-stimulated 
testosterone secretion in rat testicular tissue in vitro (Caminos et al., 2008).  
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3. Objectives  
 
Adiponectin is known to have various effects on energy metabolism and immunity. Dairy 
cows undergo several metabolic changes during the transition from late pregnancy to early 
lactation. These metabolic changes might lead to immunocompromised situations and the 
mobilization of body reserves in early lactating dairy cows. For that reason, the management 
of transition cows has been shown to be necessary to underpin production and profitability on 
dairy farms.  
A few studies have already provided results on AdipoQ in cattle, but they were mainly based 
on mRNA data. Less is known about the distribution of AdipoQ MW forms in several tissues 
and fluids; some of the above-mentioned studies have described the patterns of AdipoQ in 
humans and rodents but these results cannot be generalized for cattle. Due to the lack of valid 
bovine-specific assays, research on bovine AdipoQ has been impeded until now. We aimed to 
establish methods to quantify the amount of AdipoQ protein in serum and other body fluids. 
First, a semi-quantitative Western blot was established and validated to estimate AdipoQ con-
centrations in the serum and milk of dairy cows during the first weeks of lactation. An in-
house quantitative bovine-specific AdipoQ ELISA has been developed, which was established 
in a cooperative thesis by S.P. Singh (2014); this was applied to several samples which have 
also been used in the present thesis. Additional information about the origin and functionality 
of AdipoQ in various physiological states of cattle may be provided by a qualitative descrip-
tion of AdipoQ MW patterns. Therefore, a non-reducing, non-denaturing (semi-native) West-
ern blot protocol was developed to classify the different AdipoQ MW forms at different stag-
es of lactation and in several body fluids and tissues of cattle.  
Additionally, recombinant bovine AdipoQ was expressed and produced in Escherichia coli to 
test the functional ability of recombinant AdipoQ on lymphocyte proliferation in vitro.  
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CHAPTER II: Methodological developments and first pilot studies  
 
Western Blot (WB) is a commonly used method for determination of the presence of proteins 
by specific antibodies. The proteins are separated according to their size using sodium do-
decyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The SDS is used as a deter-
gent, which is applied to the protein samples to linearize proteins and to dissociate them from 
each other. SDS binds non-covalently to proteins to impart a negative charge so that all pro-
teins are directed to the anode whilst running in the gel (GE Healthcare handbook). After-
wards, the separated proteins are electro-transferred onto a membrane. The detection of the 
targeted protein is achieved by incubating the membrane with a specific primary antibody. A 
conjugated, e.g. horseradish peroxidase (HRP) labeled, secondary antibody is then used to 
bind the protein-primary antibody complex. The chemiluminescent substrate reacts with the 
enzyme (HRP) and the substrate produces light, which can be detected by exposing the blot to 
a digital imaging system using a camera, or by exposing the blot to an X-ray film (Fig. 4).  
 
Fig. 4: Detection of the target protein by Western blot with the use of a primary antibody (1. Ab) and a 
secondary antibody (2. Ab) labeled with horseradish peroxidase (HRP) (modified from 
www.cellsignal.com/pdf/7071.pdf) 
 
Western blot is used as a qualitative method to test for the existence of the protein of interest 
in a sample which contains various different proteins. It can also be used as a semi-
quantitative method; for that purpose, the amount of protein loaded per lane has to be identi-
cal for all samples on a given gel. After detection, the relative concentration of the target pro-
tein is estimated by comparison between the signal intensities of the sample and a control 
sample of known concentration.  
Protein
Membrane
1. Ab 
2. Ab 
HRP
Chemiluminescent
substrate
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Adiponectin is a protein which is secreted in different MW forms, as described before (Chap-
ter I_ 2.1.1.). In human serum, three different complexes of AdipoQ were detected; LMW 
(trimer) (~ 67 kDa), MMW (hexamer) (136 kDa) and HMW (multimer) (> 300 kDa) (Waki et 
al., 2003). By reducing and denaturing the samples before using them for a Western blot, it is 
possible to convert the AdipoQ multimers to monomers (Fig. 5).  
In the present thesis, a semi-quantitative Western blot protocol was established for bovine 
AdipoQ. For that purpose, we estimated the total amount of AdipoQ in a sample by compar-
ing the intensity of the samples with the intensity of a pooled sample. Total AdipoQ was de-
termined by reducing and denaturing the samples before using them in SDS-PAGE. The 
treatment generates monomers and dimers (Fig. 5B, lane 4) which were detected on the mem-
brane, the intensities of both bands were added and the relative amount of total AdipoQ was 
calculated.  
Besides the semi-quantitative Western blot, we established a semi-native Western blot proto-
col to detect the MW patterns of AdipoQ in several bovine body fluids and tissues. For this, 
the samples were neither reduced nor denatured before applying them to the SDS-PAGE, so 
that AdipoQ was visible in its native MW forms (Fig 5B, lane 1). With this method, differ-
ences in the AdipoQ MW distribution that are dependent on the physiological stage of the 
researched cattle can be identified. 
 
 
Fig. 5: (A) Structure of AdipoQ MW forms and their variation by with reducing or denaturing treat-
ment. (B) Exemplary Western blot of human serum AdipoQ treated by heat or reduction or both (mod-
ified from Waki et al., 2003) 
 
 
A B
Lane         1         2        3         4 
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The following chapter will explain the different Western blot protocols, their validation and 
first pilot studies. All buffers and solutions used for both Western blot protocols are provided 
in detail in appendix A.  
 
1. Development, validation and first application of a semi-quantitative Western blot for 
bovine adiponectin  
 
1.1. General set-up  
 
After optimization, which included identifying the optimal blotting time, gel concentration 
and antibody dilution, we established a protocol as described below.  
First, the samples were diluted with PBS and mixed with sample buffer. To estimate the 
amount of total adiponectin, it is necessary to convert the AdipoQ multimers to dimers and 
monomers. Therefore, the disulfide bonds of the multimers were reduced by dithiothreitol 
(DTT, 200 mM) and denatured by boiling (5 min, 95°C). After centrifugation for 5 min at 
10,000 × g at 4°C, 5 µl of each sample were applied to SDS-PAGE. For this, each of the sam-
ples, the reference standard and the MW marker (Precision Plus Protein WesternC Standards, 
BIO-RAD, Munich, Germany) were loaded in duplicate onto a 5.6% stacking gel and electro-
phoresed through a 12% tris-glycine polyacrylamide gel (Carl Roth, Karlsruhe, Germany). 
The gel running was performed using an SE260 mighty small II deluxe mini vertical electro-
phoresis unit (Hoefer, Inc., Holliston, MA, USA) according to the method of Laemmli (1970). 
Two gels were run simultaneously at 150 V until the dye front had proceeded almost to the 
end of the gel.  
After electrophoresis, the gels were equilibrated for 10 min in Towbin blot buffer. Before use, 
the polyvinylidene difluoride (PVDF) membranes (GE Healthcare, Munich, Germany) had to 
be activated for 10 sec in 100% methanol, washed in distilled water and then stored in blot 
buffer until further use. Six filter papers (0.7 mm, Macherey-Nagel, Düren, Germany) were 
equilibrated in blotting buffer before packing the blot sandwich. The first three filter papers 
were placed on the anode and rolled out carefully to exclude air bubbles in the blotting sand-
wich. Afterwards, the membrane with the gel on top was placed on the filter papers. To com-
plete the sandwich, the remaining three filter papers were placed on top of the pack and rolled 
out carefully to eliminate all air bubbles. Transfer of the proteins was performed with a Trans-
Blot Turbo transfer unit (Bio-Rad Laboratories, Munich, Germany) over a period of 25 min at 
25 V and maximally 1.0 A.  
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After completing the blotting procedure, the membranes had to be blocked to prevent interac-
tions between the membrane and the antibody used for the detection of AdipoQ since the 
membranes are established to bind proteins as well as antibodies. The open binding sites of 
the membrane were blocked by incubating with Tris-buffered saline containing Tween 20 
(TBST) for 60 min at RT. The membranes were exposed to the primary antibody, rab14 R-3, 
in a 1: 4000 (0.25 µg/ mL) dilution for 1 h at RT and then washed (4 x 5 min) with TBST. 
Subsequently, the membranes were treated with the secondary goat-anti-rabbit antibody, con-
jugated with horseradish peroxidase (HRP) (1:50,000; SouthernBiotech, Birmingham, AL, 
USA). After washing again (4 x 5 min), the immune complex was detected with the enhanced 
chemiluminescence (ECL) detection system (GE Healthcare, Amersham, UK, RPN 2135). 
For this, the membranes were covered by a mixture of equal volumes (500 µl) of each ECL 
detection reagent 1 and 2 in a final volume of 20 µL/cm
2
 and incubated for 5 min in the dark 
without agitation. Afterwards, the detection reagent was drained off and the membranes were 
sealed in plastic and placed in the imaging system. Imaging was performed with a VersaDoc 
MP4000 imaging system (Bio-Rad). The membranes were detected for 1 min and the band 
intensities were densitometrically analyzed via the ImageLab software (Bio-Rad).  
 
1.2. Validation of the semi-quantitative Western blot protocol  
 
Following the denaturation and reduction of serum samples, the two expected bands were 
detected: the AdipoQ monomer (~ 28 kDa) and the dimer (~ 56 kDa) (Fig. 6B). Linearity of 
the semi-quantitative Western blot was proven by estimating the coefficient of regression (R
2
) 
between the totaled band intensities per lane and against the dilution factor (Fig. 6A).  
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Fig. 6: Linearity of diluted serum samples in semi-quantitative Western blot. (A) Total intensity of 
both bands, estimated by ImageLab, was plotted against the dilution factor. (B) Exemplary Western 
blot of individual diluted serum samples. Adiponectin monomer and dimer estimated by comparison to 
the molecular weight marker 
 
Reducing and denaturing resulted in the pattern for adiponectin which had already been 
shown in human studies (Waki et al., 2003; Nakano et al., 2006). Adiponectin circulates in 
higher MW forms in human plasma. To calculate the amount of total adiponectin, it was nec-
essary to convert the multimers into monomers. The treatment used here (95°C, 5 min and 
200 nM DTT) was obviously not sufficient to destroy all disulfide bonds. The incomplete 
conversion of dimers was also shown in humans (Nakano et al., 2006). The reproducibility of 
the semi-quantitative estimation of bovine AdipoQ is shown by an intra-assay variation of 
15.7% and an inter-assay variation of 46.5%. In addition, repeated freezing and thawing of 
serum samples did not influence the estimated amount of AdipoQ.  
 
1.3. Application of the semi-quantitative Western blot protocol to characterize the con-
centration of adiponectin during lactation in serum and milk of dairy cows  
 
1.3.1. Animals and blood and milk sampling  
 
Serum samples were collected by jugular vein puncture from six multiparous Holstein dairy 
cows that were repeatedly sampled on days –21, –14, –7, 1, 7, 14, 21, 35, 49, 70, 105, 140, 
182, 189, 196, 210, 224, 238, and 252 relative to parturition. Samples were then centrifuged 
(3,000 × g, 20 min, 4°C) and serum samples were stored at -20°C until further use. 
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Milk samples (15 mL total composite milking) were taken during the morning milking proce-
dure from three multiparous Holstein dairy cows from day 5 p.p. until day 21 p.p., three times 
a week.  
 
1.3.2. Sample preparation and Western blot  
 
Serum and samples, as well as the corresponding reference standard (a pool of dairy cow se-
rum or milk samples), were diluted 1: 150 with 1× PBS, and mixed 1: 4 with sample buffer 
before loading onto the gel. The downstream protocol is described in the general set up (1.1). 
 
1.3.3. Statistical analyses  
 
The mean intensities of the bands corresponding to the monomers (28 kDa) and dimers (56 
kDa) were totaled for each lane, and then the means of the duplicates from samples and stand-
ards were calculated. Results are presented as the ratio between the sample and standard (se-
rum or milk pool) intensities. If the variation between sample duplicates was higher than 20%, 
the sample was repeated. In cases where there was variation of over 20% in the pooled sam-
ple, the whole gel was repeated. 
For evaluation of the time course of adiponectin serum concentrations in cows during late 
pregnancy and lactation, the mixed model with repeated measurement was applied with the 
use of IBM SPSS Statistics 19.0 (IBM, Ehningen, Germany).  
 
1.3.4. Results and discussion  
 
The first application of the semi-quantitative estimation of AdipoQ was performed to charac-
terize the AdipoQ concentration in serum over an entire lactation period. Serum AdipoQ con-
centrations decreased towards parturition with a nadir at day seven a.p. (Fig. 7). After parturi-
tion, the concentrations increased again until a plateau was reached for the next 252 days in 
lactation. Serum concentrations of AdipoQ were significantly lower a.p. than p.p.; in addition, 
the estimated AdipoQ concentrations of semi-quantitative Western blot correlated (r = 0.626, 
P < 0.001, n = 114) with the concentrations measured by ELISA. 
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Fig. 7: Relative adiponectin serum concentrations (means ± SEM) normalized to a standard serum 
pool in the time from late pregnancy until 252 days of lactation in 6 Holstein cows 
 
In human maternal blood, the AdipoQ concentrations decline during late pregnancy and reach 
the lowest concentrations after parturition (Fuglsang et al., 2010; Corbetta et al., 2005). De-
creasing AdipoQ concentrations towards lactation might be related to the common decrease in 
insulin sensitivity. Towards lactation, the glucose requirement of the bovine mammary gland 
increases, which leads to a decrease in the availability of glucose in adipose tissue (Bell and 
Baumann, 1997). Supporting these findings, Giesy et al. (2012) suggested that the decreasing 
AdipoQ concentrations around parturition were a physiological mechanism to improve gluco-
neogenesis and glucose supply to the mammary gland for milk production. The hormonal 
changes associated with parturition are probably related to the changes in circulating AdipoQ 
because AdipoQ expression and secretion are reportedly suppressed by prolactin and growth 
hormone in vitro (Nilsson et al., 2005). 
In view of the body fat mobilization occurring during the first weeks of lactation and the 
known inverse relationship of AdipoQ and body fat content, an increase rather than a decrease 
of serum AdipoQ concentrations was expected. The physiological priority of lactation might 
be the reason why the relationship between body fat and AdipoQ is uncoupled in favor of 
maintaining insulin resistance.  
Samples of skimmed milk could be used in Western blot without any methodical adjustment. 
Milk samples taken from 3 cows at day 5 to day 21 in the lactation period were used to esti-
mate the milk AdipoQ time course. The AdipoQ concentration in milk slightly decreased 
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throughout the first three weeks. The concentration at day 5 in lactation was 2- fold higher 
compared to the concentration at day 8 and 11 in lactation (Fig. 8).  
 
 
Fig. 8: Relative adiponectin concentrations (means ± SEM) in skimmed milk of three cows from day 5 
until day 21 in lactation 
 
Adiponectin concentration in milk appears to be the opposite of the above-described serum 
concentrations in the first weeks of lactation. Milk AdipoQ concentrations in women decline 
throughout lactation (6 months) (Martin et al., 2006; Woo et al., 2009). Since we focused on 
the first three weeks of lactation, no comparison to human concentrations within the subse-
quent months can be drawn. In line with our findings, the AdipoQ concentration in human 
early milk was higher compared to mature milk (Ley et al., 2012; Martin et al., 2006). How-
ever, contradictory results have been published; e.g. Ozarda et al. (2012) found increasing 
AdipoQ concentration in breast milk over time during lactation.  
Decreasing milk AdipoQ concentration could be explained by the rapid changes in milk com-
position during the first weeks of lactation (Blum and Hammon, 2000). 
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2. Development, validation and first application of the qualitative (semi-native) Western 
blot protocol for bovine adiponectin  
 
2.1. General set up of the semi-native Western blot  
 
The AdipoQ concentrations of all samples used in the semi-native Western blot were previ-
ously estimated using the in-house ELISA (Mielenz et al., 2013). To compare the MW distri-
bution of AdipoQ, all samples were analyzed under non-reducing, non-denaturing conditions. 
For this, samples were diluted with PBS to an equal amount of AdipoQ per lane and mixed 
with sample buffer. Before loading on the SDS gel, all samples were centrifuged for 5 min at 
10,000 × g at 4°C; 10 µl of each sample were loaded onto a 5.6% stacking gel and electro-
phoresed through an 8% tris-glycine polyacrylamide gel (Roth, Karlsruhe, Germany). The 
samples were run under reducing conditions because of the SDS contained in the running 
buffer. The gel running was performed using an SE260 mighty small II deluxe mini vertical 
electrophoresis unit (Hoefer, Inc., Holliston, MA, USA) according to the Laemmli method 
(Laemmli, 1970). Two gels were run simultaneously starting with 50 V for 15 min and con-
tinuing at 150 V until the dye front had proceeded to the end of the gel. 
Proteins separated by SDS PAGE were transferred onto a PVDF membrane by the use of tank 
blotting with the Criterion Blotter System (Bio-Rad Laboratories, Munich, Germany). For 
transferring proteins of higher molecular weight, the methanol concentration in Towbin buffer 
was reduced to 10%. The blot sandwich assembly started by placing one foam pad on the 
black wire electrode (cathode). Three filter papers soaked in blot buffer were placed above. 
Before the gel was put on top of the filters, they were rolled carefully to eliminate all air bub-
bles in the blotting sandwich. The gel on top of the filter papers was covered with the mem-
brane and three remaining filter papers. Again, the sandwich was rolled out to exclude any air 
bubbles trapped in the sandwich. Then, the second foam pad was placed on top of the blotting 
sandwich and the electrode was closed. The tank blot apparatus was filled with 1.3 L of 
Towbin blot buffer, an ice block and a magnetic stirrer. Before starting the transfer, the wire 
electrodes and the blot sandwiches were placed in the tank. The transfer was performed at 100 
V for 60 min with stirring. The blotted membranes were detected as described previously for 
the general set-up of the semi-quantitative Western blot (1.1). In addition to the Versa Doc 
detection, the membranes were detected using CL-XPosure films (Thermo Scientific, Germa-
ny) to produce sharp and intensive bands. 
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2.2. Validation of the semi-native Western blot protocol  
 
To evaluate the sensitivity of the polyclonal antibody, a serum dilution series with known 
AdipoQ concentrations (ELISA) was used. With increasing dilution, the intensity of the bands 
decreased, with the HMW band disappearing and the MMW band becoming fainter (Fig. 9). 
 
Fig. 9: Dilution series of serum samples analyzed by semi-native Western blot using 8% SDS-PAGE 
 
The serum dilution series clearly indicated that with decreasing AdipoQ concentrations, the 
HMW band was no longer visible. These findings led to the decision to use an AdipoQ serum 
concentration of 1 ng/lane for further analyses in this study. 
 
Different reducing and denaturing treatments of serum samples led to the expected differences 
in MW forms of AdipoQ (Fig. 10). The lane containing the untreated sample showed two 
bands: one HMW (> 250 kDa) and one intensive MMW (> 130 kDa) band. Heat treatment 
alone was not able to break the disulfide bonds, meaning that the bands showed the same pat-
tern as the untreated sample, by using denaturation and reduction monomers as well as residu-
al dimers of expected sizes of ~ 28 kDa and ~ 56 kDa were found.  
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Fig. 10: Characteristic changes of adiponectin MW forms with the use of denaturing and reducing 
conditions for Western blot analysis. Bovine serum (dilution 1:200) subjected to the indicated condi-
tions; 10% SDS-PAGE with or without heat denaturation (95°C, 5 min), and with or without reducing 
conditions (200 mM dithiothreitol) 
 
 
With reducing and denaturation treatment, we observed different MW forms of AdipoQ, as 
already reported for humans and mice (Waki et al., 2003). It seems that the percentage of 
MMW (hexamer) AdipoQ in bovine serum is higher than all other MW forms.  
Our bovine specific polyclonal antibody detected the same AdipoQ pattern as that observed 
previously with a bovine specific monoclonal antibody (Raffelspieper et al., 2012). In this 
study, the MMW AdipoQ band was also the most prominent, which supports the hypothesis 
that the MMW form of AdipoQ might be the most abundant in cattle.  
The distribution of AdipoQ complexes observed by gel filtration chromatography differed 
between human and mouse serum; a lower level of trimeric AdipoQ was observed in mice 
(Schraw et al., 2008). Furthermore, male subjects (humans and mice) had an equal distribu-
tion of AdipoQ, whereas females showed a decline in the proportion of complexes; HWM is 
the most abundant followed by LMW (trimer) and finally the trimer (Schraw et al., 2008).  
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Pajvani et al. (2003) showed that the portion of HMW to LMW (trimer) was different be-
tween male and female mice. Female mice had a higher ratio of HMW to LMW, whereas the 
male mice had more LMW and less HMW. The amount of LMW AdipoQ in these mice was 
not found to be different between sexes (Pajvani et al., 2003).  
The complex distribution of AdipoQ is further influenced by body fat content (lean vs. obese) 
in humans; obesity and insulin resistance lead to lower levels of the HMW AdipoQ in serum 
(Schraw et al., 2008). In addition, Kovacova et al. (2009) estimated the secreted MW com-
plexes of AdipoQ in subcutaneous (sc. AT) and viceral adipose tissue (vc. AT) in comparison 
to the distribution in serum of obese and non-obese humans. Obesity affected the secretion of 
AdipoQ MW forms in AT in a fat depot-dependent manner; it was found to be associated with 
the lower secretion of total adiponectin in sc. AT but not in vc. AT, whereas the relative pro-
portion of HMW was higher in vc. AT than in sc. AT in non-obese subjects and did not differ 
between the two depots in obese subjects (Kovacova et al., 2009).  
These findings lead to the hypothesis that bovine AdipoQ MW might also differ concerning 
adipose tissue distribution in the transition period. Therefore, we applied the newly estab-
lished AdipoQ MW blot protocol to the serum of cows from different lactation stages and 
numbers.  
 
2.3. First application of the semi-native Western blot protocol to characterize the molec-
ular weight distribution of adiponectin during lactation in serum and milk of dairy cows  
 
2.3.1. Animals and serum sampling  
 
Serum samples from eight lactating Holstein cows were analyzed to show the different MW 
forms of AdipoQ. Samples were selected from two multiparous and two primiparous cows at 
day 1 and day 105 p.p., respectively.  
Milk samples (15 mL total composite milking) were taken during the morning milking proce-
dure from three multiparous Holstein cows from day 5 p.p. until day 21 p.p., thrice a week. 
The same milk samples as those described in 1.3.1 were used. 
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2.3.2. Sample preparation and Western blot procedure  
 
Serum samples were used at concentrations of 1 ng AdipoQ/lane and skimmed milk samples 
at 0.4 ng AdipoQ/lane. The following Western blot protocol describes the general set-up of 
the semi-native Western blot (2.1).  
 
2.3.3. Results and discussion  
 
The serum concentrations estimated by ELISA at day 1 p.p. were significantly lower than on 
day 105 p.p. (Singh et al., 2014b). Different serum concentrations might be related to different 
secretion patterns of AdipoQ. Therefore, we aimed to investigate possible differences in MW 
patterns of AdipoQ between early and late lactation and concerning to the cows parity.  
The MW patterns of AdipoQ did not vary between the lactation stage and the parity of the 
cows (Fig. 11); they mirrored the regular bovine serum pattern observed before, with a strong 
MMW band and a faint HMW band.  
 
Fig. 11: Exemplary semi-native Western blot of the adiponectin molecular weight forms of dairy cows 
at different stages of lactation (Day 1 and 105 post partum (p.p.)) and different parity; multiparous 
(MP) and primiparous (PP). High molecular weight (HMW) and low molecular  weight (LMW) 
 
Neither day 1 vs. day 105 of lactation nor parity affected the MW distribution of AdipoQ. The 
available data indicate that parity can influence the pattern of changes in blood hormones and 
metabolites, since PP animals are still growing and nutrients are directed to fetal and maternal 
growth and in milk production.  
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In general, by the second lactation, maternal growth is almost completed and milk production 
has increased considerably (Coffey et al., 2006). In contrast, pregnancy in MP cows is estab-
lished during lactation and milking is usually finished about 6 wks. prior to the expected calv-
ing. The metabolic status is different in animals at the start of second and subsequent lacta-
tions (Wathes et al., 2007) and thus results in different concentrations among blood metabo-
lites of PP and MP animals. Thus the physiological reasons for variations in AdipoQ serum 
concentrations might not be related to the MW secretion patterns of AdipoQ.  
To define the MW pattern of AdipoQ in milk during early lactation, milk samples from three 
multiparous Holstein dairy cows were used.  
The AdipoQ MW patterns in mature milk were apparently not different to those seen before in 
the serum (Fig. 12). 
 
Fig. 12: Exemplary semi-native Western blot of adiponectin in milk samples from three cows on dif-
ferent days in lactation 
 
The given similarity of serum and milk AdipoQ MW patterns might indicate that milk 
AdipoQ arises from circulation into the mammary gland. However, the MW distribution in 
human milk only showed the HMW band of AdipoQ, potentially due to methodical differ-
ences. In the latter study, native PAGE was used to identify the AdipoQ MW pattern, which is 
not comparable to the semi-native Western blot method used here (Woo et al., 2009).  
Further studies of AdipoQ MW patterns in different physiological stages and in several fluids 
and tissues are described in Chapter III.  
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CHAPTER III: Molecular weight patterns of adiponectin in different body fluids and 
tissues estimated by semi-native Western blot 
 
1. Adiponectin molecular weight pattern in milk and serum samples from experimental-
ly-induced mastitis 
 
A common mastitis pathogen is the bacterium Escherichia coli (E. coli); its negative effects 
on the mammary gland are mediated by lipopolysaccharides (LPS), i.e. parts of the cell mem-
brane of gram negative bacteria. Invading pathogens induce an immune response in the 
mammary gland by activating the innate immune system, mainly neutrophils. During an im-
mune response in the mammary gland, the blood-milk barrier is negatively affected and be-
comes leaky (Burton and Erskine, 2003). This causes not only an increase in somatic cells in 
milk but also further increases the concentration of blood-borne factors in milk, e.g. BHB 
(Lehmann et al., 2013). The aim of this experiment was to examine the effect of experimen-
tally-induced mastitis on mature milk and blood AdipoQ MW patterns.  
The experimental design was described in detail previously (Lehmann et al., 2013). Briefly, 
healthy mid-lactation MP Holstein cows (n = 7) were used. All udder quarters were free of 
clinical symptoms of mastitis with SCC < 150,000 cells/mL. After the morning milking, 200 
μg E. coli LPS (serotype O26:B6; Sigma-Aldrich, Saint Louis, MO, USA) diluted in 10 mL 
0.9% sterile saline solution were infused into the left front quarter. Milk samples (~20 mL) 
from the experimental quarter were collected immediately before and 8 h after the LPS infu-
sion. Samples were skimmed (4,000 × g, 15 min, 4°C) and frozen at -20°C until analysis. 
Blood samples were collected before and 90 min after LPS infusion, and thereafter at hourly 
intervals until 8.5 h after LPS application; plasma samples were obtained by centrifugation 
(3,000 × g, 20 min) and stored at -20°C until analysis.  
For Western blot analysis, serum and milk samples taken before and after LPS challenge were 
used to characterize the potential effects of mastitis on AdipoQ MW patterns. Milk and serum 
samples were used at a concentration of 0.7 ng AdipoQ/lane. 
The distribution of AdipoQ MW complexes did not vary before and after LPS challenge, and 
neither in serum samples nor in milk samples (Fig. 13). 
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Fig. 13: Exemplary semi-native Western blot of milk (M) and serum (S) samples from cows with ex-
perimentally-induced mastitis. Samples of two (1, 2) Holstein cows before and after treatment with E. 
coli lipopolysaccharide (LPS) 
 
Although the AdipoQ concentrations in milk measured by ELISA increased after the LPS 
challenge (Singh et al., 2014a), the MW pattern of AdipoQ did not show any differences. 
Acute mammary infections are known to alter milk composition, even though these compo-
nents might not have any immunological importance, like an increase in milk lactate and BHB 
(Lehmann et al., 2013). It seems that experimentally-induced mastitis with LPS did not 
change the MW secretion pattern of AdipoQ neither in milk nor in serum, which additionally 
supports the hypothesis that milk AdipoQ arises from the circulation.  
 
2. Adiponectin molecular weight patterns in visceral and subcutaneous adipose tissue 
depots and mammary gland 
 
The following section investigates the MW patterns of AdipoQ in different AT depots at dif-
ferent stages of lactation. Adipose tissue samples from three primiparous lactating Holstein 
cows from the control group of a feeding experiment described elsewhere (von Soosten et al., 
2011) were used. The lactating dairy cows were slaughtered on either day 1, 42 or 105 of lac-
tation. Adipose tissue from three sc. depots (tailhead, withers and sternum) and three vc. de-
pots (omental, mesenteric and retroperitoneal), as well as the mammary gland, was sampled. 
Tissues were immediately frozen in liquid nitrogen and stored at -80°C until analysis.  
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After thawing the tissue samples on ice, they were homogenized in two volumes of homoge-
nization buffer using the Precellys
® 
24 homogenizer (Peqlab Biotechnologies GmbH, Erlan-
gen, Germany). Homogenates were centrifuged twice at 14,000 × g for 10 min at 4°C to sepa-
rate the fat layer. The supernatants (without fat and tissue debris) were collected and stored at 
-20°C until analysis.  
Analysis of AdipoQ MW pattern was performed by semi-native Western blot, using 0.5 ng 
AdipoQ/lane, as described in Chapter II (1.2.3 and 1.2.4).  
The characterization of AdipoQ MW patterns was done using different AT depots, homoge-
nates from vc. (mesenterial, omental, retroperitoneal) and sc. (withers, sternum, tail head) AT 
and from the mammary gland. As a reference, the corresponding serum samples were also 
loaded on the gel.  
Different AT and mammary gland homogenates showed no apparent differences in the MW 
pattern of AdipoQ. In all fat tissues a HMW and an MMW band was detectable (Fig. 14)  
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Fig.14: Exemplary semi-native Western blots of AdipoQ molecular weight pattern in adipose tissue 
(AT) extracts and serum on day 1, day 42 and day 105 of lactation. Lane 1: mesenterial AT extract; 
Lane 2: omental AT extract; Lane 3: retroperitoneal AT extract; Lane 4: wither AT extract; Lane 5: 
tail-head AT extract; Lane 6: sternum AT extract; Lane 7: serum 
 
There was also no effect of lactation stage on the MW patterns of AdipoQ in vc. and sc. AT. 
Furthermore, the variation in AdipoQ concentrations in these tissue homogenates was not 
mirrored by the AdipoQ MW pattern. No variation of serum AdipoQ MW patterns in the tran-
sition period was seen in a bovine study (Giesy et al., 2012) and within our results (see chap-
ter II). Human studies detected differences in the secretion amount and pattern in sc. AT and 
vc. AT. Subcutaneous AT plays a greater role in the release of total and HMW AdipoQ (Mey-
er et al., 2013).  
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The ratio of secreted HMW versus total AdipoQ in vc. AT and sc. AT explants was higher in 
non-obese subjects compared to obese humans (Kovacova et al., 2012); however, our cows 
were not obese, and actually had a body condition score of 3 (Pappritz et al., 2011). There-
fore, changes in AdipoQ concentrations might not be reflected by changes in the MW patterns 
of AdipoQ in bovine AT.  
In view of AT samples obtained through biopsies or collected after exsanguination at slaugh-
ter, the samples might contain residual blood. Singh et al. (2014b) estimated that the amount 
of residual blood in the tissue samples with the use of the transferrin concentration in the tis-
sue preparations and in serum was able to correct for blood-derived AdipoQ. However, the 
estimated blood content in AT samples was negligible (>1%) in tissue samples derived after 
exsanguination and was low (5% of mg total protein) in biopsy samples (Singh et al., 2014b). 
 
The expression of AdipoQ in mammary glands was detected by Western blot (Fig. 15); the 
patterns were similar to those found for serum and milk previously (Chapter II, 2.3.3.).  
 
Fig. 15: Adiponectin molecular weight pattern in the bovine mammary gland (MG) estimated by semi-
native Western blot 
 
The expression of AdipoQ mRNA in the bovine mammary gland was previously reported 
(Saremi et al., 2014; Ohtani et al., 2011). Only a marginal expression of AdipoQ mRNA in 
mammary gland was found (Saremi et al., 2014; Giesy et al., 2012), which is not in support of 
parenchyma being a meaningful source of AdipoQ. However, the expression of AdipoQ re-
ceptors in the mammary gland indicates a physiological relevance of AdipoQ in milk produc-
tion. Adiponectin receptor mRNA abundance in the mammary gland increased during the 
course of lactation (Saremi et al., 2014).  
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The similarity of mammary gland AdipoQ MW patterns to serum AdipoQ MW may indicate 
that AdipoQ from serum is mainly present in the mammary gland homogenate. This may fur-
ther explain the low expression of AdipoQ mRNA in the mammary gland; the low signal 
might contribute to stromal adipose cells, which might be part of the homogenate. The low 
AdipoQ mRNA expression in mammary glands during lactation was accounted for by the 
decreasing number of stromal adipose cells in lactating mammary glands (Ohtani et al., 2011). 
 
3. Adiponectin molecular weight patterns in cerebrospinal fluid (CSF) 
 
Cerebrospinal fluid (CSF) is a liquid which surrounds the central nervous system. The hypo-
thalamus and the brainstem are parts of the brain and are involved in the regulation of feed 
intake. Cerebrospinal fluid contains blood metabolites and hormones whose concentrations 
depend on the functioning of the blood brain barrier. Consequently, CSF hormone and metab-
olite concentrations differ from those in the blood. As already mentioned in the literature re-
view of Chapter I, dairy cows tend to develop a negative energy balance in the transition peri-
od, which is caused by reduced feed intake and increasing milk production. One part of the 
regulation of feed intake is played by adipokines, which circulate in blood and CSF at differ-
ent concentrations. Leptin decreases in serum and CSF after calving, whereas ghrelin, the 
counterpart of leptin, did not vary in concentration (Laeger et al., 2013). As AdipoQ is one of 
the most abundant adipokines in circulation and as this study showed a decrease in serum 
concentration around parturition, we were interested in studying the pattern of AdipoQ in the 
CSF of dairy cows around parturition. 
Cerebrospinal fluid samples were collected from ten German Holstein dairy cows at day −20, 
−10, +1, +10, +20, and +40 relative to parturition and were provided by Dr. B. Kuhla, Leib-
nitz Institute of Farm Animal Biology (FBN) Dummerstorf. The details of the experiment are 
described elsewhere (Laeger at el., 2013). Briefly, the CSF from spinal cord was obtained by 
lumbar puncture and blood was withdrawn from the jugular vein before morning feeding. 
Blood samples were centrifuged at 1,573 × g for 20 min and CSF samples at 4,566 × g for 5 
min (each at 4°C). Plasma and CSF aliquots were frozen in liquid nitrogen and stored at 
−80°C until analysis (Laeger at el., 2013). The semi-native Western blot procedure was con-
ducted according to the method described in Chapter II (1.2.3 and 1.2.4). The concentration of 
0.7 ng AdipoQ/lane was used for serum samples and CSF was used at a concentration of 0.3 
ng AdipoQ/lane.  
CHAPTER III: Molecular weight patterns of adiponectin in different body fluids and tissues   35 
Generally, the AdipoQ concentration in serum was about 80-fold higher compared to that in 
CSF. At Day -20 and +40 relative to parturition, serum AdipoQ concentrations were 1.2-fold 
higher compared to day +1 and +10, as confirmed by ELISA measurement. Cerebrospinal 
fluid and serum samples of individual days in the transition period showed no apparent differ-
ences in the MW pattern of AdipoQ (Fig. 16).  
The MMW band was the most prominent one in all cases, whereas the HMW tended to be 
faint in all samples, independent of whether serum or CSF was analyzed. 
 
Fig. 16: Exemplary semi-native Western blot of AdipoQ molecular weight patterns in cerebrospinal 
fluid (CSF) and corresponding serum samples (S) from one cow 
 
In contrast to AdipoQ MW patterns found herein for bovine CSF, human CSF did not show 
any HMW band, neither by Western blot (Neumeier et al., 2007) nor by gel filtration chroma-
tography and subsequent semi-quantitative Western blotting (Kusminski et al., 2007). Our 
results also showed no differences between serum and CSF MW patterns of AdipoQ. The 
most abundant band of AdipoQ was the MMW in both serum and in CSF. Furthermore, the 
MW pattern in serum or CSF did not differ at different stages of the transition period. Alt-
hough there were variations in serum AdipoQ concentrations in the transition period, which 
have already been described in Chapter II (2.1.1) the MW pattern of AdipoQ did not vary 
(Chapter II 2.2.2). The transfer of AdipoQ through the blood brain barrier, which had already 
been shown in human studies (Kusminski et al., 2007; Neumeier et al., 2007), might explain 
the similarity of MW patterns found in serum and CSF.  
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4. Adiponectin in Bovidae other than Bos taurus  
 
As Yak, Bison and Water buffalo are also used for milk and meat production it is of interest to 
compare the distribution of AdipoQ MW patterns to Bos taurus. In Europe, buffalos are main-
ly used for milk production. A characteristic of buffalo milk is the high percentage of both 
protein and fat in the milk, although the average milk yield per lactation is much lower com-
pared to dairy cattle (Rosati and Van Vleck, 2002) which might protect buffalos from suffer-
ing metabolic changes during the transition period.  
Our aim was to investigate AdipoQ patterns in cattle other than Bos taurus. Therefore, blood 
samples from Yak (Bos grunniens) and American Bison (Bison bison) were obtained during 
routine diagnostic blood sampling from a private farm in Bavaria and were made available by 
the veterinarian practitioners in charge: Dr. Christiane Grassl and Dr. Anton-Peter 
Grassl, Baierbach, administrative district of Landshut. Blood and milk samples from Water 
buffalo (Bubalus bubalis) were from the Farfengo Farm of the Labuaq buffalo milk company, 
Cremona, Italy and were made available through a DAAD-funded cooperation (Vigoni-
Program) by Dr. Fabrizio Ceciliani, Dipartimento di Scienze Veterinarie e Sanità Pubblica 
Via Celoria 10, University of Milan, Milan, Italy. 
These samples were also used in the semi-native Western blot procedure, as described in 
Chapter II (1.2.3 and 1.2.4). AdipoQ blood concentrations in Yak and Bison were estimated 
by ELISA; for their detection in Western blot, a concentration of 0.7 ng AdipoQ/lane (~ 1:250 
dilution) was used. The serum and milk samples of Water buffalo were not detectable in 
ELISA because of missing parallelism and assay accuracy exclusively for Water buffalo sam-
ples; therefore, the Water buffalo serum was diluted 1:250 and the milk 1:10.  
Semi-native Western blot analysis of blood and milk samples yielded signals in all samples. 
The MW patterns of AdipoQ in Yak, Bison, Water buffalo and buffalo milk were mostly the 
same (Fig. 17); a prominent MMW band (~ 130 kDa) and a HMW band (> 250 kDa) were 
detected in all samples. Generally, the pattern is comparable to that seen before in the serum 
and milk of Bos taurus.  
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Fig. 17: Exemplary semi-native Western blot of serum and milk samples from different bovine spe-
cies, applied in duplicate 
 
The fact that Water buffalo could not be assayed for their serum and milk AdipoQ content by 
ELISA might be due to a matrix effect in the ELISA. The antibody detects AdipoQ in all 
three species of bovidae and the AdipoQ patterns in buffalo samples were not different to the 
others. Matrix effects are a common problem experienced by immunoassays, but few have 
been reported. Reasons for matrix effects are various; one possible factor is hindrance of an 
interaction between antigen and antibody (Lee et al., 2004). The estimated AdipoQ blood 
concentrations for Yak and Bison samples were well within the range of serum concentrations 
for Holstein dairy cows (Mielenz et al., 2013) i.e. 21.0 ± 0.4 µg/mL .  
 
5. Adiponectin molecular weight patterns in allantoic fluid of dairy cows  
 
The gene expression of AdipoQ and its receptors in human and rat placental tissue has been 
reported (Caminos et al., 2005). As there are significant differences between human and ru-
minant placenta types (haemochorialis vs. syndesmochorialis), the major source of circulating 
AdipoQ in neonates may differ in ruminants compared with humans. In addition, it was hy-
pothesized that the estimated AdipoQ concentration in amniotic fluid is of fetal origin, be-
cause of the absent correlations with serum AdipoQ concentrations (Baviera et al., 2007). We 
aimed to characterize AdipoQ MW patterns and concentration in allantoic fluid (AF) and the 
corresponding serum of Holstein dairy cows. Samples of AF were collected during cesarean 
sections at the clinic for cattle in the University of Veterinary Medicine, Hanover, Germany 
from four Holstein dairy cows.   
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Directly after surgery, maternal blood samples were collected into EDTA tubes (Sarstedt AG 
& Co., Nümbrecht, Germany), centrifuged (1,000 x g, 15 min, 4°C) and then the plasma ob-
tained was stored at -20°C until further analysis.  
The mean plasma AdipoQ concentrations in cows subsequent to cesarean section were 19.8 ± 
0.7 µg/mL, whereas the concentration in AF (2.6 ± 0.7 ng/mL) amounted to only 0.01% of the 
plasma values. There was no correlation between detectable AF concentrations and maternal 
plasma samples. The MW pattern of AdipoQ in AF was different from that in plasma (Fig. 
18): the HMW form was the dominant form, whereas only faint bands were detectable in the 
MMW size range. In contrast, in the corresponding maternal plasma samples, both HMW and 
MMW were present. 
 
Fig. 18: Exemplary semi-native Western blot of AdipoQ molecular weight forms in maternal plasma 
(P) and allantoic fluid (AF) of four Holstein cows 
 
Besides, we observed differences in MW of AdipoQ between AF and plasma. The HMW 
form of AdipoQ was present at higher concentrations in AF than in plasma; furthermore, 
HMW AdipoQ was the main band detectable in AF. Possible explanations might be that the 
protein is secreted by allantoic epithelial cells or could be of fetal origin. Supporting our ex-
planation, incubated tissue explants of human placenta and amnion showed a basal release of 
AdipoQ (Lappas et al., 2005). In addition, PCR analyses of different fetal tissues in humans 
showed positive results for AdipoQ mRNA in amniotic membrane samples (Corbetta et al., 
2005). Moreover, Corbetta et al. (2005) could not find a correlation between fetal and mater-
nal serum AdipoQ concentrations.   
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With their findings, they hypothesized that the placenta does not contribute to fetal AdipoQ 
blood concentrations, which is in line with our findings. Possible explanations might include 
the fact that the protein is secreted by fetal tissue (Sivan et al., 2003). 
Further applications of semi-native Western blot are given in Chapter IV.  
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ABSTRACT 
Adiponectin (AdipoQ), an adipocyte-derived hormone, is one of the most abundant 
adipokines in the blood circulation. Adiponectin has various metabolic functions, such as im-
proving insulin sensitivity in humans and in rodents. The role of AdipoQ in reproduction is 
not yet fully understood, but the expression of AdipoQ in reproductive tissues has been ob-
served in various animals and humans, including chicken testis, bovine ovary and human pla-
centa. The objective of this study was to characterize AdipoQ in the bovine body fluids relat-
ed to reproduction. Therefore, we evaluated the seminal plasma (SP) from breeding bulls (n= 
29) and follicular fluid (FF) from heifers (n= 14), and we also collected blood samples from 
these animals. In addition, blood samples from other bulls (n = 30) and heifers (n = 14) were 
assayed for AdipoQ. The concentrations were assessed using a bovine-specific ELISA, and 
the molecular weight (MW) pattern of the AdipoQ protein was estimated by Western blot 
(WB) analysis. The SP AdipoQ concentrations were approximately 180-fold lower compared 
to the serum concentrations. Furthermore, the AdipoQ concentrations in the serum and SP 
were positively correlated. The molecular weight patterns of AdipoQ in the serum and SP 
were different such that the high MW form of AdipoQ was more abundant in the SP than se-
rum. The AdipoQ concentrations in the serum and SP also increased with age: Old bulls (> 6 
years) had higher AdipoQ concentrations in the serum and SP than bulls ≤ 24 months of age 
(P < 0.05). In the FF, the AdipoQ concentrations were 1.6-fold lower than in the correspond-
ing serum samples, and the concentrations in the serum and FF were not correlated (P > 0.1). 
In the FF, only the middle MW forms of AdipoQ were detectable by Western blotting. The 
MW pattern in the serum did not differ between the sexes. Our data provide both the AdipoQ 
concentration and MW patterns for bovine body fluids related to reproduction.  
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1. Introduction 
Adiponectin (AdipoQ) is one of the most abundant adipokines that is present in the µg/mL 
range in the blood circulation. Adiponectin is predominantly secreted by adipocytes [1] and 
has potential benefits on insulin sensitivity [2] and also has anti-inflammatory activity [3]. 
Adiponectin exerts its effects by activating a range of different signaling molecules via bind-
ing to two transmembrane AdipoQ receptors, AdipoR1 and AdipoR2. AdipoR1 is expressed 
primarily in the skeletal muscle, whereas AdipoR2 is predominantly expressed in the liver [4]. 
The major signaling molecules activated by AdipoQ are adenosine monophosphate-activated 
protein kinase (AMPK), p38 mitogen-activated protein kinase (p38-MAPK) and the transcrip-
tion factors peroxisome proliferator-activated receptor (PPAR) -α and nuclear factor kappa-
light-chain-enhancer (NF-κB) [4]. AdipoR1 acts mainly via the APMK pathway, thus inhibit-
ing fatty acid oxidation, whereas AdipoR2 acts through PPARα signaling, which stimulates 
fatty acid oxidation [5]. Adiponectin is synthesized as a single 28 kDa monomer but is not 
secreted as such; instead it undergoes multimerization to form different molecular weight 
(MW) multimers prior to secretion [6]. Adiponectin is found in the circulation in three differ-
ent MW forms as follows: a trimer with low MW (LMW, 67 kDa), a hexamer with middle 
MW (136 kDa) and a multimeric form of 12 – 18 monomers with high MW (HMW, > 300 
kDa). The AdipoQ monomer is only detectable after reducing and denaturation [6]. The 
HMW AdipoQ is considered the most biologically active form [7]. The potential effects of 
AdipoQ on reproduction have been addressed in various studies. Adiponectin may affect the 
female and the male reproductive system at different levels, through both central and local 
regulatory mechanisms. AdipoQ expression was observed in several species in different types 
of ovarian cells. Adiponectin mRNA was detected in chicken theca cells and, to a lesser ex-
tent, in the granulosa cells of follicles during different stages of maturation [8]. In cows, 
AdipoQ mRNA was detected in the theca, granulosa and cumulus cells as well as the oocyte 
[9]. In rat ovaries, the AdipoQ protein was immunohistochemically localized in theca-
interstitial cells, corpus luteum and oocytes and lesser amounts were detected in granulosa 
cells [10]. By contrast, AdipoQ mRNA was reported to be absent/low in a human granulosa 
cell line as well as mouse and human granulosa and cumulus cells [10, 11]. Moreover, in situ 
hybridization localized the AdipoQ mRNA in adipose tissue adherent to the ovary but not in 
any ovarian cells in mice [11]. However, the expression of the AdipoQ receptors AdipoR1 
and AdipoR2 was consistently confirmed in ovarian tissues from chicken, mouse, human and 
cattle [8, 10, 11].  
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AdipoQ may function in the ovary during steroidogenesis, although basal or FSH-stimulated 
steroidogenesis in primary rat granulosa cells was not affected by treatment with recombinant 
AdipoQ, and co-stimulation with insulin or insulin-like growth factor 1 (IGF-1) increased 
both progesterone and estradiol production [10]. By contrast, AdipoQ decreased insulin or 
IGF-1 induced progesterone production in bovine granulosa or theca cells [12, 13], and these 
inhibitory effects were primarily located in theca cells [12]. AdipoQ may also function in fe-
male reproduction during maturation of the oocyte; however, there are conflicting results. In 
cattle, adiponectin did not modify oocyte maturation in vitro, whereas the meiotic maturation 
of pig oocytes derived from follicles (3-6 mm diameter) was supported by recombinant por-
cine AdipoQ [14]. These results indicate that species differences may exist with regard to the 
specific ovarian response to AdipoQ.  
For male reproduction, the AdipoQ protein was localized in the peritubular cells and Leydig 
cells of the chicken testis [15]. The Leydig cells were also positive for AdipoQ in the rat testis 
[16]. AdipoQ expression is less responsive to gonadotropins than metabolic signals, suggest-
ing a function of AdipoQ as endocrine integrator linking metabolism and gonadal function 
[16]. AdipoR1 and AdipoR2 mRNA were observed in several testicular cells types and were 
higher in adult versus prepubertal chickens [15]. Androgens, particularly testosterone, are 
inversely related to the serum AdipoQ concentrations in humans [17] and mice [18], and 
treatment with recombinant AdipoQ inhibits testosterone secretion ex vivo [16]. Human semi-
nal plasma (SP) is the male body fluid related to reproduction and reportedly contains AdipoQ 
at concentrations approximately 66-fold lower than serum. In addition, a positive correlation 
between the AdipoQ concentrations in both matrices was observed [19]. In human follicular 
fluid (FF), the concentrations of AdipoQ reach approximately 20 to 25% of the corresponding 
serum samples and are positively correlated with the serum values [20, 21]. In addition to the 
differences in AdipoQ concentrations, the isoforms of AdipoQ differ between the serum and 
FF. In the FF, the LMW form of AdipoQ is the most abundant fraction, whereas in the serum, 
the HMW fraction is predominant [22].  
Studies of AdipoQ in cattle have been impeded by the lack of validated, species specific as-
says. There is one report of the serum AdipoQ concentration in bulls that were determined by 
an ELISA using an anti-human goat antibody [23]. However, the concentrations reported 
were approximately 100-fold lower than that expected based on the data published for humans 
and rodents [1]. 
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The present study investigates the AdipoQ concentrations and MW patterns in bovine serum, 
FF and SP. Our objectives were as follows: (1) determine the AdipoQ concentrations and MW 
patterns in the serum and SP of breeding bulls and (2) characterize the AdipoQ in the serum 
and FF longitudinally during the estrous cycle in heifers. 
 
2. Materials and methods 
 
2.1. Bulls  
2.1.1. Seminal plasma and blood samples  
Blood and semen samples were collected at the same day from bulls owned by the bull stud 
center of the cattle breeding association “Rinder Union West e.G.” in Borken, Germany. 
Blood samples were collected by jugular venipuncture from 59 bulls (Holstein: n = 56, Li-
mousin: n = 1, Pinzgauer: n = 2; average age 37 ± 31 months (mean ± SD), median = 24 
months, range = 11 months to 12 years). The samples were allowed to clot for 2 h before cen-
trifugation (1,000 × g, 15 min, 4 °C), and the sera obtained were stored at -20 °C until further 
analysis.  
The semen samples were obtained during the semen collection routine from 29 of the 56 Hol-
stein bulls using an artificial vagina. One mL of the ejaculate collected from each bull was 
centrifuged (10,000 × g, 10 min, 4 °C), and the supernatant (SP) was stored at -20 °C.  
 
2.1.2. Estimation of sperm characteristics  
The volume of each ejaculate was recorded by weighing, and the density was estimated by 
photometry. The motility of the spermatozoa was estimated using Computer Assisted Sperm 
Analysis (CASA) with SpermVision™ (Minitüb GmbH, Tiefenbach, Germany). The varia-
bles characterizing the motility were total motility (tMOT), progressive motility (pMOT) and 
local motility (lMOT). In addition, the percentage of dead cells (not moving) was recorded. 
For 2 of the 29 ejaculates obtained, the motility data were not available. The pMOT was > 
75% for all bulls (85.1 % ± 19.0%, means ± SD, range 77.0 – 96.1%), except for 3 bulls that 
had azoospermia.  
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2.2. Female animals and sample collection  
2.2.1. Follicular fluid  
Simmental heifers (n = 14; 15-20 months old) from the Training and Research Center 
Frankenforst, of the University of Bonn were synchronized by intramuscular (i.m.) admin-
istration of 500 µg cloprostenol (PGF2α, Estrumate
®
; Essex Tierarznei, Munich, Germany) 
twice within 11 d. Two days after each PGF2α treatment, the animals received 10 µg GnRH 
(i.m.) (Receptal
®
; Intervet, Boxmeer, The Netherlands). The third day after the last PGF2α 
injection was day 0 of the estrous cycle.  
The blood samples and ovaries were collected from animals sacrificed at d 3 (n = 6), 7 (n = 3) 
or 19 (n = 5) after the onset of estrus as confirmed by rectal palpation by an experienced vet-
erinarian. Only heifers with a contracted uterus at day 0 were classified as in estrus. The fol-
licular fluid was collected from the dominant follicle (8-12 mm diameter) from each animal. 
The blood samples were centrifuged at 1,500 × g, 4 °C for 20 min after clotting for 2 h. The 
serum and FF were stored at -20 °C until further use.  
To determine the serum concentrations during the estrous cycle in more detail, serum samples 
were obtained on days 0, 3, 6, 10, 12, 14, 17 and 19 of the estrous cycle from 14 additional 
Simmental heifers (24 - 28 months old) synchronized as described above.  
 
2.3. Assessment of the concentrations and molecular weight forms of adiponectin 
2.3.1. Quantitative assessment of the adiponectin concentrations by ELISA 
The serum, SP and FF were analyzed in duplicate for AdipoQ using a competitive ELISA 
developed in-house as described previously [24]. Assay accuracy was confirmed by establish-
ing the linearity of serially diluted samples. The range of the assay was 0.07-1.0 ng/mL, and 
the limit of detection was 0.03 ng/mL. The intra- and interassay coefficients of variation 
(CVs) were 7 and 9%, respectively.  
 
2.3.2. Western Blot  
Western blot analysis was performed to determine the different molecular weight forms of 
AdipoQ in the different body fluids. The samples were used without reducing and heat-
denaturing.  
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2.3.2.1. Sample preparation 
The AdipoQ concentrations assessed via ELISA were used to standardize the amount of sam-
ple subjected to electrophoresis and Western blotting for the same AdipoQ concentrations. 
Prior to the comparative analyses, the amount of AdipoQ per lane allowing for optimal dis-
play of the different MW forms in each body fluid was tested and optimized. The final con-
centrations of the fluids were standardized as follows: serum 1 ng; SP 0.5 ng; and FF 1 ng. 
Approximately equal concentrations of AdipoQ per sample were loaded by diluting the sam-
ples with PBS 
 
2.3.2.2. Western blot procedure  
The diluted samples were mixed with sample buffer (final concentration: 0.064 M Tris HCl 
pH 6.8, 1% SDS, 0.01% bromophenol blue, and 10% glycerol). Before loading on 8% SDS 
gels, the samples were centrifuged for 5 min at 10,000 × g, 4 °C. The proteins separated by 
SDS-PAGE were transferred onto polyvinylidene diflouride membranes (PVDF) (GE 
Healthcare Europe, Freiburg, Germany) using tank blotting with the Criterion Blotter System 
(Bio-Rad Laboratories, Munich, Germany). After blotting, the membranes were blocked with 
Tris-buffered saline containing 0.05% Tween 20 (TBST) and 10% Roti
®
-Block (Carl Roth, 
Karlsruhe, Germany) for 60 min at room temperature (RT). The membranes were exposed to 
primary antibody (0.25 µg/mL) (same as the ELISA) for 1 h at RT and washed 4 times with 
TBST containing 0.05% Tween 20. Similarly, the membranes were treated with a secondary 
goat-anti-rabbit antibody conjugated with horseradish peroxidase (1:100,000; 
SouthernBiotech, Birmingham, AL, USA). After washing, the immune complex was detected 
with an enhanced chemiluminescence detection system (GE Healthcare) using CL-XPosure 
film (Thermo Scientific, Munich, Germany). The MW of the bands detected was assessed by 
comparison with a MW marker (Precision Plus Protein™ WesternC™ Standards, BioRad). 
Where appropriate, the intensity of the bands was quantified densitometrically using the 
VersaDoc MP4000 imaging system with Image Lab software (Bio-Rad, Munich, Germany), 
and the ratio between the intensities of the bands corresponding to the MMW and HMW was 
calculated. 
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2.4. Statistical analyses  
All statistical analyses were performed using SPSS (IBM SPSS Statistics 21, Ehningen, Ger-
many). The data are presented as the means ± SEM, and significance was P-values < 0.05, 
whereas P < 0.1 was considered a trend. The normal distribution of all data was tested using 
the Kolmogorov-Smirnov test. 
The AdipoQ concentrations in the serum and SP were compared between each of the 3 age 
and 3 motility groups (described below) by non-parametric Mann-Whitney-U test. Testing for 
correlations between different variables was performed with either Pearson correlation for 
normally distributed data or Spearman Rho correlation when the data were not normally dis-
tributed.  
To test for potential temporal differences throughout the estrous cycle, a general linear model 
with repeated measurement was used. The model included pair-wise comparison with 
Bonferroni correction to evaluate differences between the individual days of the estrous cycle. 
To test for the potential effects of age, the samples obtained from the bulls were classified as 
follows: bulls ≤ 24 months of age (n = 30; 16 ± 1 months of age, average body weight 446 ± 
20.7 kg), bulls > 2 and ≤ 6 years (n = 22; 44 ± 4 months, 891 ± 45.4 kg) and bulls > 6 years (n 
= 8; 102 ± 22.4 months, 1050 ± 40.5 kg). 
To assess potential differences in the MW pattern from the samples obtained from bulls with 
different sperm quality, pools of both serum and SP were generated from animals based on 
their different progressive spermatozoa motility (pMOT). Groups were generated as follows: 
bulls with ≥ 90% pMOT (n = 14; 93.4 ± 0.4%), bulls ≥ 80% and < 90% pMOT (n = 5; 86.8 ± 
0.8%), bulls < 80% pMOT (n = 5; 77.1 ± 2.86%) and azoospermic bulls (n = 3).  
 
3. Results 
3.1. Adiponectin concentrations and MW patterns in bull sera and seminal plasma  
The AdipoQ concentrations in the serum (31.1 ± 1.42 µg/mL) were higher (P < 0.001) than 
the SP (0.18 ± 0.01 µg/mL). The serum and SP AdipoQ concentrations were correlated as 
shown in Fig. 1. The mean ratio between the serum and SP AdipoQ was 180 ± 41. The serum 
AdipoQ concentrations from the 3 non-Holstein bulls were well within the range described 
here.  
Comparison of the AdipoQ concentrations in the serum and SP between the different age 
groups showed that the oldest bulls (>73 months) had higher concentrations than the young (≤ 
24 months) and middle aged (25-72 months) animals (Fig. 2).  
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For all age groups, the serum and SP concentrations were correlated with age (r = 0.458, P < 
0.05 and r = 0.380, P < 0.05, respectively; Spearman-Rho correlation). However, when the 
correlations were calculated within the age groups, the correlations between the serum and SP 
AdipoQ were limited to the young (n = 13) and middle aged (n = 10) animals (r = 0.752 and r 
= 0.807, P < 0.01, respectively), whereas for the old bulls (n = 6), no such relationship (r = 
0.551, P = 0.257) was observed. The ratio between the serum and SP AdipoQ concentrations 
was not different between the age groups. Based on the various semen characteristics record-
ed, no relationship was observed for the AdipoQ concentrations in the serum or SP. The only 
exception was the group of old bulls in which progressive and total sperm motility were in-
versely correlated with the serum AdipoQ concentrations (r = -0.886, P < 0.05). In general, 
sperm motility increased with age.  
The seminal plasma differed from the serum for the MW patterns of AdipoQ (Fig. 3). The 
intensity of the HMW band in SP was approximately 5-fold higher than in serum. The ratio 
between the MMW and LMW AdipoQ bands was lower in the SP than in serum.  
3.2. Adiponectin concentrations and MW patterns in heifer sera and in follicular fluid  
The adipoQ concentrations in the serum and FF obtained from the dominant follicle remained 
fairly constant during the estrous cycle (Fig. 4A). On average, the AdipoQ concentrations in 
the FF (19.4 ± 1.4 µg/mL) were approximately 60% of serum (31.8 ± 1.5 µg/mL). The serum 
and FF AdipoQ concentrations during the estrous cycle were not correlated (r = -0.434, P > 
0.1, n=14, Pearson correlation). When blood samples were repeatedly collected at higher fre-
quency from additional animals across the estrous cycle, a variation (P < 0.01) over time was 
observed (Fig. 4B). On day 10 of the estrous cycle, the lowest concentrations of AdipoQ were 
observed, which were approximately 1.2-fold lower than on day 3 and day 0 (P < 0.046 and P 
< 0.009, respectively).  
The MW patterns of AdipoQ in the FF differed from the serum as shown in Figure 5. The 
HMW band was virtually absent in the FF independent of the stage of the estrous cycle. 
 
3.4. Adiponectin serum concentrations in male versus female cattle 
The mean serum concentrations of AdipoQ differed between the heifers and bulls of approxi-
mately the same age, at 15 to 28 months. The bulls had lower (P = 0.002) serum AdipoQ con-
centrations than the heifers (25.1 ± 0.9 vs. 31.0 ± 1.5 µg/mL).  
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4. Discussion  
The presence of AdipoQ in bovine SP and FF was detected. Using a bovine specific ELISA 
developed in-house [24], the AdipoQ concentrations in the SP and FF were quantified and 
compared with the serum values. The applicability and validity of this ELISA for SP and FF 
was confirmed by parallelism of serial dilutions with the standard curve. In both the SP and 
FF, the AdipoQ concentrations were lower than in the corresponding serum samples. Western 
blot analysis was used to characterize the MW forms of the AdipoQ protein in SP and FF and 
yielded divergent MW patterns in the different body fluids. 
Adiponectin in seminal plasma and serum of bulls  
The AdipoQ concentrations in the SP were approximately 180-fold lower than the corre-
sponding serum concentrations. Thomas et al. [19] reported that the AdipoQ concentrations in 
the SP of men were approximately 66-fold lower than the concentrations in serum and were 
correlated. The authors suggested that AdipoQ is transferred from the blood to testis tissue, 
particularly via gaps in the blood testis-barrier. The correlation (Spearman-Rho) observed in 
the current study between the serum and SP AdipoQ concentrations in bulls supports the hy-
pothesis that SP AdipoQ originates from the blood. 
The lack of correlation between the serum and SP concentrations in the old bulls may be ex-
plained by the small number of animals in this group. However, the MW patterns of AdipoQ 
in bull sera and SP were different. In the serum, the MMW was the primary band, whereas 
only a faint band for the HMW was observed. Similar MW patterns of the AdipoQ protein in 
serum were shown for dairy cows [24, 25, 26]. In contrast to the serum, the SP exhibited a 
prominent HMW band in addition to the MMW band, which was also present. The composi-
tion of SP is affected by its production sites, including the rete testis, epididymis, and accesso-
ry sex glands [27], which may differ in their blood-tissue barrier functions. In addition, the 
proximity to adipose tissue, particularly visceral adipose tissue, may also contribute to the 
relatively higher portion of HMW AdipoQ in SP. The ratio of HMW/total AdipoQ was higher 
in visceral adipose tissue, which also comprises gonadal fat, than in subcutaneous fat [28]. 
Moreover, SP in contrast to FF, is not a transudate from the blood but results from secretion 
processes at its various sites of production. The composition of SP deviates from blood serum 
in many respects, and the concentration of anorganic and organic constituents may affect the 
formation of AdipoQ multimers. For example, the concentration of calcium in bovine SP is 
approximately 3 times higher than in the blood serum [29], and calcium promotes the for-
mation of HMW AdipoQ [30].  
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SP AdipoQ may function on spermatozoa because AdipoR1 and R2 mRNA is expressed in 
bull spermatozoa [23]; however, the relationships between the SP AdipoQ concentrations and 
functional sperm characteristics were not established in this study for either bulls or humans 
[19].  
Age dependent differences in adiponectin concentrations  
The increase of AdipoQ concentrations in the serum with age for bulls is consistent with ob-
servations in aging humans [31, 32]. In men, this age-related increase of serum AdipoQ con-
centration is more pronounced than in women. Our results are limited to bulls because the age 
range of the heifers here was 15 to 28 months. However, when comparing cows up to 4 lacta-
tions from previous studies, the AdipoQ serum concentrations were greater in multiparous 
than primiparous lactating cows from day -21 pre partum until day 252 during lactation [33]. 
One possible explanation for the increase of AdipoQ serum concentrations with age in bulls 
may be changing sex hormone concentrations over the lifespan. Testosterone concentrations 
decrease with increasing age in men [34], and testosterone and 5α-dihydrotestosterone sup-
press AdipoQ secretion from cultured adipocytes [18]. However, inconsistent results regard-
ing the influence of AdipoQ on testosterone and vice versa are published. For example, testos-
terone and AdipoQ are positively correlated in men [35], whereas in rats, a negative correla-
tion was found [36].  
In bulls, no increase in testosterone with age was detected [37] in animals 8.5 to 18 months of 
age, which is equivalent to the age of the young bulls in the present study. By contrast, a re-
cently published study showed a highly positive correlation between the serum AdipoQ and 
testosterone concentrations in bulls. The increase of serum AdipoQ concentrations with in-
creasing fertility was similar to the testosterone concentrations [23]. However, the absolute 
serum AdipoQ concentrations in the aforementioned study were approximately 100-fold low-
er than for monogastric species and cows [1, 24]; therefore, the values cannot be directly 
compared.  
In addition, we observed lower serum AdipoQ concentrations in young bulls (< 24 months of 
age) than young cows of about the same age. However, we cannot rule out that this difference 
may be attributable to different environmental conditions and different breeds because the 
bulls were primarily Holstein Frisians, whereas the heifers were all Simmental). The body fat 
content, which depends on both the breed and sex, may also contribute to this observation. 
Interestingly, for the bulls, the correlations between the serum and SP AdipoQ differed be-
tween the age groups.  
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The oldest bulls showed no correlation between the serum and SP, whereas in the young and 
middle aged bulls, high correlations (r = 0.752, r = 0.807, respectively, P < 0.05, Spearman-
Rho correlation) were observed. However, the missing correlation in the old bulls may be 
because of the few (n = 6) animals in this group. The correlations within the 2 other age 
groups and across all bulls further supports that AdipoQ from the blood may be the main 
source of AdipoQ in the SP.  
Adiponectin in the serum and FF during the estrous cycle  
The serum AdipoQ concentrations varied during the estrous cycle and were lowest at day 10 
in the animal group that was repeatedly sampled. In cattle, the serum concentrations of pro-
gesterone increase from estrus to day 10 and then plateau until luteolysis, whereas appreciable 
increases of estradiol-17ß are limited to the time of estrus [38]. Increasing progesterone con-
centrations, although not assessed here, may be related to the decrease in serum AdipoQ at 
day 10 of the estrous cycle because progesterone treatment decreases AdipoQ mRNA expres-
sion in the inguinal fat of female rats [39].  
The concentrations of total AdipoQ in the FF from heifers were on average 62% of the corre-
sponding serum samples. In swine (prepubertal gilts), the AdipoQ concentrations in the FF 
were 80 - 90% of the serum [40]. It should be noted that all data for the AdipoQ concentra-
tions in human FF are from patients undergoing ovarian stimulation, such that the samples 
were obtained after gonadotropin treatment.  
The concentrations of total AdipoQ in these FF samples as 22-29% of the serum values and 
were strongly correlated to each other [20, 22]. For the heifers in our present study, the 
AdipoQ concentrations in the blood serum and FF were not correlated, but this may be be-
cause of the relatively few animals from which both FF and blood were obtained in parallel. 
In the bovine ovary, AdipoQ and its receptors are expressed at both the mRNA [9] and protein 
levels [13]. The presence of AdipoQ mRNA in bovine oocytes, theca, cumulus and granulosa 
cells supports the hypothesis of local production sites for FF AdipoQ. AdipoQ mRNA was 
expressed in the adipose tissue adherent to the mouse ovary [11], this adipose tissue is a likely 
source of AdipoQ in the FF. Adiponectin mRNA expression varied throughout follicular de-
velopment, and the granulosa and cumulus cells of large follicles had 2-fold higher expression 
than small follicles [9]. However, we did not observe any differences in the FF AdipoQ con-
centrations between small and large follicles in ovaries collected from two cows at a local 
abattoir (data not shown). The divergent MW pattern we observed in the FF versus serum 
indicating that there was relatively less HMW AdipoQ in the FF is consistent with reports in 
humans.   
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The percentage of HMW adiponectin in human FF was 11% of that in serum versus 21% and 
45% of the MMW and LMW, respectively [22]. The follicular fluid is a product of both the 
transfer of blood plasma constituents across the blood follicular barrier and the secretory ac-
tivity of granulosa and theca cells [41]. The local secretion of AdipoQ from ovarian cells into 
the FF may occur [13], and transudation of AdipoQ from the blood to FF has been previously 
suggested [21]. For the latter, the relative concentrations of the different MW forms in the FF 
versus serum may be altered because the amount of proteins in the FF depends on the MW of 
the protein, and the amount decreases as the MW increases [42].  
 
4.1. Summary and conclusions  
We have demonstrated that the AdipoQ concentrations in the SP and FF are lower than the 
corresponding blood values. Furthermore, the MW patterns of the AdipoQ varied between the 
SP and FF but not between serum samples. In addition, no sex-related differences in the MW 
patterns were observed. Correlations between the reproductive body fluids and the corre-
sponding blood values were established for the SP only, but due to the limitations in the num-
ber of females studied, correlations may also exist for the FF. Therefore, we conclude that the 
AdipoQ concentrations in the SP are likely blood borne and originate from the adipose tissue, 
and the potential contribution of local secretion from the testes, if any, is only marginal. For 
the AdipoQ present in the bovine FF, transudation from the blood but also local secretion is 
feasible.  
In the present study, increasing age was associated with increasing serum and SP AdipoQ 
concentrations in bulls. The functional importance of AdipoQ in the reproductive fluids re-
mains to be elucidated. 
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Figure 1: Correlation of serum and seminal plasma (SP) adiponectin (AdipoQ) [µg/mL] concentra-
tions in Holstein breeding bulls (n = 29) 
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Figure 2: Scatter plots of the adiponectin (AdipoQ) concentrations in serum (A, n = 59) and in semi-
nal plasma (SP, B, n = 29) of breeding bulls classified according to their age in 3 different groups 
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Figure 3: Molecular weight patterns of adiponectin (AdipoQ) in bulls` serum (S) and seminal plasma 
(SP). (A) Exemplary Western blot of AdipoQ multimeric isoforms under non-reducing and non heat-
denaturing conditions. Samples were proportionately pooled from groups classified according to the 
progressive motility (pMOT) of spermatozoa. 1: bulls with ≥ 90% pMOT (n = 14: 93.4 ± 0.4%), 2: 
bulls with ≥ 80% and < 90% pMOT (n = 5: 86.8 ± 0.8%) and 3: bulls with < 80% pMOT (n = 8: 48.2 
± 13.2%). (B) Exemplary lane profile of serum and SP samples showing different intensities in high 
molecular weight (HMW) and middle molecular weight (MMW) bands 
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Figure 4: Changes in adiponectin (AdipoQ) concentrations (means ± SEM) during estrous cycle in 
follicular fluid (FF) and in serum.  
(A) Adiponectin concentrations in follicular fluid (FF) and in serum from Simmental heifers (n = 14) 
sampled at targeted slaughter at 3 different days of the estrous cycle. LP = luteal phase; FP = Follicu-
lar phase. *: P < 0.05 for differences between serum and FF AdipoQ concentrations.  
 (B) Changes in serum AdipoQ concentrations of Simmental heifers (n = 14) sampled repeatedly dur-
ing the estrous cycle; different letters indicate differences (P < 0.05) between time points 
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Figure 5: Exemplary Western blot of adiponectin (AdipoQ) multimeric isoforms under non-reducing 
and non heat-denaturing conditions in serum (S) and in follicular fluid (FF) of 4 heifers, 2 in luteal 
phase and 2 in follicular phase (day 3 and day 19 of the estrous cycle, respectively). High molecular 
weight (HMW) and middle molecular weight (MMW) bands 
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CHAPTER V: Recombinant production of adiponectin and functional studies  
 
Recombinant proteins are biotechnologically produced proteins which were expressed by ge-
netically modified bacteria, yeast, insect cells or mammalian cells. With the use of recombi-
nant protein production in E. coli, a fast and high yield method for protein expression was 
developed. To purify proteins from crude extracts, affinity tags could be used as highly effi-
cient tools. Affinity tags are peptide sequences which are genetically grafted onto a recombi-
nant protein. The advantage of using fusion proteins to facilitate the purification and detection 
is well-recognized and many different purification protocols are available (Terpe, 2003). Re-
combinant proteins are often used for antibody generation, as standards in quantitative detec-
tion systems or for the investigation of functional effects.  
In the following chapter, the expression of recombinant AdipoQ linked with an affinity tag, its 
purification and testing of its effects on lymphocyte proliferation are described.  
 
1. Material and methods 
 
1.1. Vector generation with IBA Star Gate Cloning 
 
Adiponectin was produced by a combinatorial cloning procedure from IBA bioTAGnology 
GmbH, Göttingen, Germany. The cloning procedure was carried out according to the manu-
facturer’s instructions. 
 
1.1.1. Donor vector generation  
 
Beginning with the amplification of the AdipoQ gene, cDNA from bovine sc. AT was used to 
amplify the AdipoQ gene by PCR. Additionally, the AdipoQ gene was equipped at both ter-
mini with combinatorial sites, the StarCombinase recognition area and a cleavage site for fac-
tor Xa. The StarCombinase recognition is important for the oriented insertion of AdipoQ into 
the entry vector. The Primers (Tab. 2) were designed using the StarPrimer D’Signer software, 
as recommended in the manual.  
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Table 2: Characteristics of the primers  
Name 
accession 
number 
Sequence 
Length of PCR 
product (bp) 
Bos taurus 
AdipoQ 
NM_174742.
2 
forward: 
3’AGCGGCTCTTCAATGATTGAGGGTC
GCGAGGACAACATGGAAGATCC’5 
reverse: 
5’AGCGGCTCTTCTCCCTTCAACAATG
TTATGGTAGAG’3 
711 
 
After the amplification of the AdipoQ gene by PCR, the PCR product was checked for size 
and quality in an agarose gel (1.0%). The size of the PCR product was estimated by compar-
ing the band size with those of the marker ΦX174 DNA/BsuRI (HaeIII) Marker, 9 (Thermo 
Fisher Scientific, Waltham, MA, USA).  
The second step in the cloning procedure was purification of the PCR product using a com-
mercial kit (innuPREP DOUBLEpure Kit, Analytikjena, Jena, Germany). Briefly, two ali-
quots of the PCR product (100 µl in total) were mixed with 1000 µl binding buffer and mixed. 
The purification column was loaded with the mix of buffer and PCR product, centrifuged 
(10,000 x g, 2 min, RT) and then loaded again until the PCR product was used up and the 
binding of the PCR products had been completed. The elution of the PCR products was 
achieved as follows: 18 µl elution buffer were loaded onto the column and incubated for 1 h 
at RT. Finally, the PCR products were harvested by centrifugation (8,000 x g, 1 min, RT), and 
the flow-through was collected and used for further cloning procedures.  
The third step of donor vector generation was insertion of the amplified AdipoQ DNA into the 
entry vector. The entry vector was provided in a reaction tube into which 2 nM of the AdipoQ 
DNA and the StarSolutions M1, M2 and M3 had to be added. After gentle mixing, the tube 
was incubated for 1 h at 30°C. Meanwhile, the competent E. coli Top 10 cells were thawed. 
After incubation, the transformation into E. coli Top 10 cells was achieved by adding 10 µl of 
the entry vector reaction mixture to the cells. Afterwards, the tube was incubated for 30 min 
on ice, then gently mixed, incubated for 5 min at 37°C, mixed again and incubated for a fur-
ther 3 min on ice. After transformation of the entry vector into E. coli cells, 900 µl Luria 
Bertani (LB) (Carl Roth, Karlsruhe, Germany) medium were added and a further incubation 
of 45 min at 37°C followed. To culture the transformed E. coli cells, 100 µl of the cell sus-
pension were plated in duplicate on an LB agar plate which contained 50 mg/L kanamycin 
and 50 mg/L X-gal (AppliChem, Darmstadt, Germany).  
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Finally, these plates were incubated at 37°C overnight. The next morning, a liquid culture and 
a master plate were made. Single colonies from the agar plate were picked and transferred 
either into a tube containing LB-medium or on an LB-agar (Carl Roth, Karlsruhe, Germany) 
plate.  
 
1.1.2. Verification of the correct insertion of adiponectin by restriction analysis  
 
The transformed bacteria, from the liquid night culture, were used for restriction analysis. 
First, the DNA was extracted by the QIAprep Spin Miniprep Kit (Qiagen, Hilden, Germany), 
according to the instructions provided in the manual. The procedure is based on the alkaline 
lysis of bacterial cells and is followed by adsorption of the DNA onto a silica membrane. 
Three basic steps were necessary, beginning with preparation and clearing of the bacterial 
lysate. Then, the DNA was absorbed onto the QIAprep membrane and the plasmid DNA was 
finally washed and eluted.  
The extracted plasmid DNA concentration was estimated by NanoDrop™ (PEQLAB 
Biotechnologie GMBH, Erlangen) measurement.  
The restriction analysis was carried out with 1 µg of extracted DNA and the restriction en-
zymes XbaI and HindIII (Thermo Fisher Scientific). The restriction was necessary to confirm 
the insertion of AdipoQ DNA into the entry vector. XbaI recognizes T^CTAGA sites and 
HindIII A^AGCTT sites in DNA at a temperature optimum of 37°C. The samples were pre-
pared with Tango Buffer (Thermo Fisher Scientific), DNA and both restriction enzymes. The 
restriction program was run in a thermal cycler (Peltier Thermal Cycler, PTC 200, MJ Re-
search, Watertown USA) for 4 h at 37°C, followed by 20 min at 80°C to stop the enzyme ac-
tivity, and samples were held at 4°C until the samples were taken out of the cycler.  
Verification of the restriction analysis was done by electrophoresis with a 1% agarose gel. 
Additionally, the sequence of the obtained PCR product had to be confirmed, since PCR may 
lead to mutations and improper product ends. Therefore, the restricted plasmid, with the ap-
propriate primers provided in the cloning kit, was sent to a sequencing company (SeqLab, 
Sequence Laboratories GmbH, Göttingen, Germany). 
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1.1.3. Destination vector generation and transformation in E. coli  
 
After sequence confirmation of the AdipoQ insert, the procedure was continued by cloning 
the donor vector plasmid into different acceptor vectors (see table 3) to generate the final des-
tination vectors. The use of different tags provided the possibility to select the optimal combi-
nation of the expression patterns of the protein (soluble form or inclusion body) and to choose 
a specific protein purification system. The appropriate acceptor vector was mixed with the 
donor vector and with StarSolutions A1 to A3 followed by a short incubation (for 1 h at 
30°C).  
 
Table 3: Different affinity tags of the acceptor vectors  
Acceptor vec-
tor 
IBA 4 IBA 35 IBA 25 IBA 105 
N-terminal Tag 
Strep Tag + 
signal sequence 6 His Tag GST Tag One strep 
Tag Size (bp) 106 32 653 104 
Strep: synthetic streptavidin; 6 His: polyhistidine-tag; GST: Glutathione S-transferase; One strep: tan-
dem Strep tag. 
 
Afterwards, the destination vector was transformed into E. coli Top 10 cells, as described in 
1.1.1. To verify the insertion of AdipoQ into the destination vector, the cells were plated on 
LB agar plates containing ampicillin and X-gal. Blue/white staining was used as a transfor-
mation indicator. The desired destination vector, including the AdipoQ gene, will generate 
white colonies, whilst non-desired acceptor vectors, i.e. those not bearing the target gene in-
sert, will generate blue colonies. This is caused by the insertion of the LacZ gen in the accep-
tor vectors, which produces blue stained colonies in the presence of X-gal. If AdipoQ is in-
serted properly, the LacZ gene is replaced and the colonies stay white. Finally, white colonies 
were taken for overnight culture. Subsequently, the insertion of AdipoQ was verified by re-
striction analysis, as explained in 1.1.2.  
 
1.2. Protein overexpression in E. coli  
 
First, a pre-culture was prepared with 100 mL LB media containing 100 mg/mL Ampicillin 
(AppliChem). Transformed E. coli were taken either directly from a colony on an agar plate 
or from a previously prepared glycerin stock. A small amount of cells was sufficient for the 
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pre-culture. A pipette tip was dipped into the colony and put into the LB media flask. Grow-
ing of the cells was achieved overnight (16-18 h) under shaking (350 rpm) at 37°C.  
The next morning, the main culture was prepared in four Erlenmeyer flasks with 200 mL LB 
media each, supplemented with 100 mg/mL Ampicillin. The main culture was inoculated by 
gradually pipetting the pre-culture into the freshly prepared LB media until an optical density 
(OD) of 0.1 was reached at 578 nm. The culture was incubated for at least 1h before the next 
measurement of growth of the culture. The aim was to reach an OD between 0.4 and 0.5. If 
0.5 was reached, a zero sample was taken, centrifuged (5000 rpm, 5 min) and then the pellet 
was resuspended in 20 µl SDS-PAGE sample buffer (5X) and frozen (-21°C) until further use. 
Out of each fresh culture, a glycerin stock (300 µl glycerin + 500 mL culture) was generated 
and stored frozen at -21°C.  
The overexpression of AdipoQ by E. coli Top 10 cells was induced by adding 200 µl 
Anhydrotetracycline (200 ng/mL) (AppliChem, Darmstadt, Germany) to the main culture. To 
check the expression level of AdipoQ, a sample of 1 mL was taken hourly over a duration of 4 
h. These samples were centrifuged (5000 rpm, 5 min), the supernatant was drained off and the 
pellet was resuspended in 20 µl SDS-PAGE sample buffer (5X) and frozen (-21°C) until fur-
ther use in SDS-PAGE. After 4 h, the overexpression was stopped by centrifugation (5000 
rpm, 15 min, 4°C) of the whole culture medium. The supernatant was collected in a tube and 
frozen (-21°C) until further use in SDS-PAGE; the remaining pellet was treated likewise. 
 
1.3. Protein purification  
 
1.3.1. Sonication procedure  
 
Sonication was used to identify whether the recombinant AdipoQ remained soluble in the 
cytoplasm or was accumulated in insoluble aggregates.  
The residual cell pellets from the expression were thawed on ice, weighed and resuspended in 
Lysis- Equilibration-Washing (LEW) Buffer. The pellets were dissolved in 20 vol. of LEW 
Buffer. Afterwards, the cell solution was sonicated (Sonoplus SH 70G, Bandelin electronics, 
Berlin, Germany) three times for 1 min on ice followed by high speed centrifugation (18,000 
x g) for 30 min at 4°C. The resulting supernatant was drained. From each part (supernatant 
and pellet), a small sample (~10 µl, or pipette tip) was taken for testing in SDS-PAGE. The 
supernatant was supplemented with one tablet protease inhibitor (cOmplete Protease Inhibitor 
Cocktail Tablets, Roche, Basel, Switzerland) before it was frozen (-20°C), together with the 
remaining pellet.  
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To verify the different expression patterns of the AdipoQ protein for each vector, SDS-PAGE 
analysis with subsequent coomassie staining of the gel was used. A 10% Tris tricine gel was 
loaded with pellets dissolved in sample buffer (5X) and the corresponding supernatant in 
sample buffer (5X); all samples were boiled at 95°C for 5 min. The gel runs were performed 
at 120 V for approximately 2 h. Gels were stained overnight in coomassie; the next day they 
were destained and analyzed by comparing the band sizes with the molecular weight marker.  
Based on the different expression patterns of the vectors (given in 2.2.2.), we decided to fur-
ther continue the AdipoQ expression with the His-tagged protein.  
 
1.3.2. Purification of His-tag adiponectin  
 
For purification, the Protino
®
 Ni-TED Resin (Macherey-Nagel, Düren, Germany) was used. 
The recombinant polyhistidine-tagged proteins were purified by immobilized metal ion affini-
ty chromatography. The resin was dry silica-based and pre-charged with Ni
2+ 
ions. Interaction 
between the His-tag of the recombinant protein and immobilized Ni
2+ 
ions caused the binding 
of the protein to the resin. Tris-carboxymethyl ethylene diamine (TED) is a strong metal 
chelator with six binding sites for metal ions. Five binding sites are occupied in the coordina-
tion sphere; the remaining coordination site of Ni
2+ 
is left to bind the protein (Fig. 19). 
 
Fig. 19: Binding of a Polyhistidine-tagged protein to Protino® Ni-TED (schematic illustration) A: 
Protino
®
 Ni-TED, a silica bead, bearing the metal chelator with bound Ni2+ ion. B: One Histidine 
residue of the Polyhistidine-tag of the recombinant protein binds to the resin. 
(MACHEREY-NAGEL – 01 / 2011, Rev. 04) 
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The purification procedure was carried out as a gravity flow column chromatography under 
native conditions. Two different buffers were necessary for equilibration, washing and elution 
(see appendix A). 
First, the supernatant was thawed at 4°C and sterile filtered (0.2 µm, Sartorius). Then, 10 mL 
supernatant were mixed with 1.5 g resin and incubated under shaking for 1.5 h at RT. After 
incubation, the supernatant resin mix was transferred into a 14 mL column (Macherey–Nagel, 
Düren, Germany). Before washing, the flow-through was collected. Afterwards, the resin was 
washed twice with 12 mL LEW buffer; each washing step was collected in separate tubes. 
Elution was performed in six steps with 6 mL elution buffer used for each step. All eluents 
were collected in separate tubes. Finally, the resin was washed once with 15 mL LEW buffer 
to remove residual elution buffer. All buffers and the resin were used more than once; there-
fore, they were stored at 4°C until further use.  
The purity of the eluted protein was verified by SDS-PAGE. For this purpose, a 10% tricine 
glycine gel was run with samples of all washing and elution steps from one purification pro-
cedure. The protein bands were detected by silver staining (Page Silver, Fermentas, St Leon-
Rot, Germany). 
 
1.3.3. Concentration and buffer exchange 
 
Buffer exchange was necessary because of the imidazole in the elution buffer, which is not 
recommended for further use. Vivaspin columns (5 kDa molecular weight cutoff, Sartorius, 
Göttingen, Germany) were used for buffer exchange and the subsequent concentration of pro-
tein solutions. The elution aliquots from one supernatant were pooled and carefully trans-
ferred into the Vivaspin columns.  
The columns were centrifuged (3000 × g, 30 min at 4°C) until 10 mL supernatant were left in 
the tube; then, the tube was filled up with the elution pool again. This was repeated until the 
whole elution pool was used and only 10 mL eluent were left in the column. Afterwards, the 
elution buffer was exchanged by LEW buffer. The 10 mL concentrated eluent in the vivaspin 
column was filled up with LEW buffer and centrifuged again until 10 mL solution were left. 
This step was repeated until 100 mL LEW buffer had run through the column and a final vol-
ume of 5 mL protein solution was left. Protein concentration was measured by photometer at 
280 nm. The extinction was multiplied with the specific AdipoQ extinction factor (1. 0463), 
which was calculated using Protein calculator v.3.3. 
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1.4. Endotoxin removal  
 
Protein expression in E. coli is associated with endotoxin contamination. Endotoxins consist 
of lipopolysaccharides (LPS), which are structural components of the outer cell membrane of 
all gram-negative bacteria. A single E. coli cell contains about 2 million LPS molecules 
(Magalhães et al., 2007). In conditions where the body is exposed to LPS, a systemic inflam-
matory reaction can occur, leading to multiple pathophysiological effects, such as endotoxin 
shock, tissue injury, and death (Erridge et al., 2002). However, endotoxin does not act directly 
against cells or organs but through activation of the immune system, especially through mon-
ocytes and macrophages, with the release of a range of proinflammatory mediators, such as 
tumor necrosis factor (TNF), interleukin (IL)-6 and IL-1. Pyrogenic reactions and shock are 
induced in mammals and birds upon intravenous injection of endotoxin at low concentrations 
(1 ng/mL) (Magalhães et al., 2007; Wang et al., 2003). 
The purified protein solution was applied to an endotoxin removal resin (Pierce
® 
High- Ca-
pacity Endotoxin Removal Spin Column, 0.5 mL, Thermo Fisher Scientific). These columns 
contain porous cellulose beads, which have been modified at their surface with poly-L-lysine. 
This modified polylysine has a high affinity to endotoxins.  
The procedure was performed according to the manual. Briefly, the endotoxin binding occurrs 
at pH 6-8, so all buffers were adjusted and the protein was tested further. First, the column 
was equilibrated to RT and regenerated by 0.2 M NaOH. Afterwards, the column was treated 
with 2 M NaCl, centrifuged (500 × g, 1 min) and followed by a washing step with endotoxin-
free water. The last step before the protein solution was loaded, a washing step with endotox-
in-free buffer, was repeated three times. Then, the protein solution (3.5 mL) was incubated 
overnight at RT under shaking conditions (120 rpm). The next day, the endotoxin-free protein 
solution was collected by centrifugation (500 × g, 1 min) of the column and was stored at 4°C 
until further use.  
 
1.4.1. Limulus Amebocyte Lysate Test 
 
The endotoxin concentration was determined by the Pierce
®
 LAL Chromogenic Endotoxin 
Quantitation Kit (Thermo Fisher Scientific, USA). Bacterial endotoxin catalyzes the activa-
tion of a pro-enzyme in the modified Limulus Amebocyte Lysate (LAL).  
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The activated pro-enzyme catalyzes the splitting of p-Nitroaniline from a colorless substrate; 
the activation rate is proportional to the sample endotoxin concentration. After stopping the 
reaction, the released p-Nitroaniline is photometrically measured (405-410 nm). 
The procedure was done according to the instructions of the provided manual. Briefly, prepa-
ration of the endotoxin standard stock solutions was performed first. All of the steps were 
done at 37°C on a heating plate. All standards and samples were pipetted into a 96-well plate 
and incubated for 5 min. Then, the LAL was added and incubated for exactly 10 min, before 
the substrate was added and incubated for 6 min. Finally, the reaction was stopped by 25% 
acetic acid (100 µl per well) and the extinction was measured at 410 nm.  
 
1.5. Application of recombinant adiponectin to test its effects on lymphocyte prolifera-
tion 
 
The periparturient period of dairy cows is characterized by a state of immunosuppression, 
which may result in increased susceptibility towards infectious disease at that time. The im-
mune function and the non-specific host defense mechanisms are altered (Mallard et al., 
1998), e.g. functional properties of lymphocytes and monocytes are modulated by parturition 
and energy balance (Lessard et al., 2004). In particular, the secretion of cytokines like TNFα 
and INFγ increases after parturition. Furthermore, the proliferative response of PBMC in mul-
tiparous dairy cows was lower one week before calving than three weeks before and after 
calving (Lessard et al., 2004).  
We aimed to investigate the effect of AdipoQ on mitogen-stimulated lymphocyte prolifera-
tion.  
 
1.5.1. Animals 
 
Blood samples were taken by jugular vein puncture from six multiparous Holstein cows at 
day 100 ± 7 in lactation. Blood (15 mL) was collected in tubes containing 10 EU heparin/mL 
blood (Biochrom AG, Berlin, Germany).  
The blood sampling was approved by the North Rhine-Westphalia State Agency for Nature, 
Environment and Consumer Protection (LANUV-NRW, file number 8.87- 51.05.20.10.258, 
Recklinghausen, Germany). The dairy cows were housed at the experimental research farm of 
the Faculty of Agriculture, Frankenforst, University of Bonn, Germany. 
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1.5.2. Isolation of peripheral blood mononuclear cells  
 
Peripheral blood mononuclear cells (PBMC) were isolated by gradient centrifugation. The 
heparinized (10 EU/mL) blood was diluted 1:2 with PBS and carefully layered over lympho-
cyte separation medium (LSM, PAA, Pasching, Austria).  
Afterwards, the cells were centrifuged (1100 × g, 30 min, 21°C) without using the break. The 
PBMCs were harvested from the interface and washed with PBS by centrifugation (430 × g, 
10 min, 4°C). The supernatant was drained off and the residual erythrocytes were lysed by 
resuspending the cell pellet in 20 mL cold (4°C) distilled water. The hypotonic lysis was bal-
anced by adding 20 mL 2X PBS. Subsequently, the cells were washed (430 × g, 10 min, 4°C). 
Again, the supernatant was removed and the cells were resuspended in RPMI 1640 medium, 
supplemented with 100 U Penicillin/mL, 100 mg/mL streptomycin (AppliChem) and 10% 
FCS (RPMI 1640-S). Further media components are described in appendix A. 
 
1.5.3. Isolation of monocytes and lymphocytes  
 
The affinity of monocytes to bind to plastic was used to isolate monocytes and lymphocytes 
by adherence. Resuspended PBMCs were layered on Petri dishes (Greiner GmbH, Nürtingen, 
Germany) and incubated for 1.5 h at 37°C. After incubation, the non-adherent lymphocytes 
were washed off the Petri dish with pre-warmed (37°C) RPMI 1640 medium and collected in 
a separate 14 mL Falcon tube (Sarstedt, Nümbrecht, Germany). The monocytes were collect-
ed by rinsing with cold (4°C) PBS and by gentle mechanical scraping (Cell scraper, Sarstedt). 
Both cell types were washed (430 × g, 10 min, 4°C) and resuspended in RPMI 1640. Viability 
and cell count was estimated by Trypan blue and counting in a Neubauer counting chamber. 
After counting, the cells were finally washed (430 × g, 10 min, 4°C) and resuspended in 
freezing medium. Subsequently the cells were aliquoted into cryo vials (Sarstedt) and directly 
frozen at -80°C.  
The purity of isolated cells was estimated by flow cytometry (FACSCalibur, Becton Dickin-
son, Heidelberg) using forward and side scatter, and that was kindly made available by Prof. 
Dr. H. Ilges, (Immunology and Cell Biology, Department of Natural Science, Bonn-Rhein-
Sieg University of Applied Science)  
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1.5.4. Isolation of granulocytes  
 
Out of the remaining cells after the PBMC isolation (mainly erythrocytes and granulocytes) 
by density gradient centrifugation (1.5.2), granulocytes were isolated by repeated hypotonic 
erythrocytes lysis. First, the plasma and LSM which was left in the centrifugation tube on top 
of the erythrocyte and granulocyte pellet was discarded. Subsequently, the pellet was diluted 
in 20 mL cold (4°C) distilled water and inverted several times. The osmotic imbalance was 
adjusted by adding 20 mL 2X PBS into the falcon tube. Then, the cells were washed (430 × g, 
10 min, 4°C), the supernatant was drained off and the cells were again resuspended in 20 mL 
distilled water. The procedure was repeated twice.  
Finally, the remaining granulocytes were resuspended in RPMI 1640-S. The viability and cell 
count was estimated by Trypan blue staining. After final washing (430 × g, 10 min, 4°C), the 
cells were resuspended in freezing medium, aliquoted in cryo vials and directly frozen at -
80°C. 
The purity of isolated cells was estimated by flow cytometry (FACSCalibur) using forward 
and side scatter (see above). 
 
1.6. Test protocol for assessing lymphocyte proliferation  
 
The preparation of cells was initiated by warming (up to 37°C) the RPMI 1640-S medium and 
thawing the lymphocytes. For that purpose, the cryo vials were incubated at 37°C in a water 
bath, for no more than 1 min, to prevent complete thawing. Afterwards, the lymphocytes were 
washed (300 × g, 8 min, RT) in 20 mL warm (37°C) RPMI 1640-S medium. The supernatant 
was drained off and the pellet was resuspended in 1 mL warm (37°C) RPMI 1640-S medium. 
Then, the cells were counted (Neubauer counting chamber) and tested for viability by Trypan 
blue staining. The desired amount of cells was 1× 10
6 
lymphocytes per mL and the cells were 
accordingly diluted and pipetted in 100 µl aliquots into a 96-well plate (Sarstedt); the outer 
wells, on the left and right side of the plate, were used as blank (only contained RPMI 1640-S 
medium). Lymphocytes were cultured in quintuplicates, either with or without Concanavalin 
A (ConA, Sigma-Aldrich, St. Louis, MO, USA) stimulation. The ConA stock solution (1 
mg/mL) was thawed and diluted to a final concentration of 10 µg/mL in RPMI 1640-S; 50 µL 
ConA solution were pipetted into half of the wells on the plate.  
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The wells in the other half of the plate (unstimulated cells) were adjusted to the same volume 
with 50 µL RPMI 1640-S medium per well. Each well of the plate contained a volume of 150 
µl in which lymphocytes were either stimulated (+ConA) or unstimulated (-ConA). 
 
1.6.1. Preliminary testing the effect of LPS on lymphocyte stimulation  
 
Before testing the effect of recombinant AdipoQ on lymphocyte proliferation, we tested the 
potential influences of LPS contamination. Concerning the potential LPS contamination of the 
recombinant AdipoQ solution, we tested the effect of different LPS concentrations on stimu-
lated (+ConA) and non-stimulated (-ConA) lymphocytes. For that purpose, we used pure E. 
coli endotoxin at different concentrations of 0.4 ng/mL up to 100 µg/mL (0.4 ng, 1.6 ng, 10 
ng, 100 ng, 1 µg, 10 µg, 100 µg/mL) diluted in RPMI 1640-S. The different final concentra-
tions of LPS were applied to the lymphocytes in 50 µl aliquots. 
 
1.6.2. Testing the effect of adiponectin on lymphocyte proliferation 
 
After preparation of the 96-well plate for the proliferation test, as described in 1.6, the lym-
phocytes were stimulated with two different AdipoQ concentrations (20 and 60 µg/mL). The 
AdipoQ stock solution (0.1 mg/mL) was dissolved in RPMI-S and pipetted (50 µL) into each 
of the wells, excluding the blank wells and the control wells without AdipoQ stimulation, as 
described in Table 4. In each of the plates, lymphocytes from two individual cows were used 
and tested in quintuplicate, with or without ConA and with either 0, 20 or 60 µg/mL AdipoQ. 
 
Table 4: Layout for an exemplary 96-well plate of AdipoQ stimulated lymphocyte proliferation test 
with two individual cows. Blanks denote wells containing only medium, grey highlighted wells are the 
wells stimulated with ConA, the not highlighted wells are the unstimulated ones, and numbers indicate 
the AdipoQ concentration in µg/mL 
 
  1 2 3 4 5 6 7 8 9 10 11 12 
C
o
w
 1
 
A Blank 0 0 0 0 0 0 0 0 0 0 Blank 
B Blank 20 20 20 20 20 20 20 20 20 20 Blank 
C Blank 60 60 60 60 60 60 60 60 60 60 Blank 
D Blank Blank Blank Blank Blank Blank Blank Blank Blank Blank Blank Blank 
C
o
w
 2
 
E Blank 0 0 0 0 0 0 0 0 0 0 Blank 
F Blank 20 20 20 20 20 20 20 20 20 20 Blank 
G Blank 60 60 60 60 60 60 60 60 60 60 Blank 
H Blank Blank Blank Blank Blank Blank Blank Blank Blank Blank Blank Blank 
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When the pipetting had been completed, the plate was incubated for 72 h at 37°C and 5% 
CO2. Thereafter, the plate was centrifuged (200 × g, 5 min, RT) and 100 µl medium superna-
tant were removed into a new empty 96-well plate and frozen at -80°C. Afterwards, 10 µl 
Thiazolyl Blue Tetrazolium Bromide (MTT, AppliChem) (5 mg/mL) was pipetted into each 
well and incubated for a further 4 h at 37°C, 5% CO2. After 4 h, the lymphocytes were lysed 
with 100 µl lysis solution per well. Before measuring the extinction, the plate was kept over-
night in a drawer at RT to completely dissolve the blue crystals. The next morning, the OD in 
each well of the plate was determined at 570 nm with a microtiter plate reader (EL800; Bio-
Tek Instruments). The calculation of the stimulation index (SI) started by subtracting the 
mean OD of the blanks from each individual OD measurement. Then the “blank-corrected” 
mean OD of each qiundruplicate with ConA stiumulation was divided by the “blank-
corrected” mean of the respective quindruplicates of the cells without ConA stimnulation.  
 
 
1.7. Statistical analysis of the lymphocyte proliferation test 
 
All statistical analyses were done using SPSS 20.0 software (IBM, Ehningen, Germany). The 
results are displayed as means ± SEM and the level of significance was set at P ≤ 0.05; a trend 
was defined as 0.05 > P ≤ 0.05.  
The stimulation index data were tested for normal distribution by the Kolmogorov-Smirnov 
test and for homogeneity of variance by the Levene’s test. Normally distributed and homoge-
neous variances data were tested by the parametric one-way ANOVA test. For group-wise 
comparison, the post hoc Bonferroni correction was applied. 
 
2. Results and Discussion  
 
2.1. Production of bovine recombinant adiponectin  
 
2.1.1. Amplification of the adiponectin gene 
 
The successful amplification of the AdipoQ gene by PCR was verified in a 1% agarose gel, in 
which a band with the expected PCR product size of 711 bp (Fig. 20) was obtained. The total 
sequence of the own sequencing result of bovine AdipoQ gene is available in appendix B. 
mean OD of stimulated cells
mean OD of unstimulated cells
SI =
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Fig. 20: Electropherogram (1% agarose gel) of the AdipoQ gene after PCR product purification. The 
sample was loaded in duplicate and size was estimated by comparison with the marker bands 
 
2.1.2. Verification of the donor vector  
 
The correct insertion of AdipoQ DNA into the donor vector was verified by restriction analy-
sis with Hind III and XbaI. The unrestricted plasmid used as a control showed two bands, i.e. 
the round plasmid DNA with a size of 1830 bp and the coiled DNA, which is much bigger. 
The duplicate of clone 8 showed a band of 1830 bp, which corresponds to the plasmid and a 
band at 711 bp which is equivalent to the AdipoQ insert (Fig. 21). 
 
Fig. 21: Electropherogram (1% agarose gel) of the restricted donor vector with Hind III and XbaI. The 
restriction fragments are shown before (plasmid) and after restriction; the AdipoQ insert showed the 
expected size of 711 bp. The negative control (NTC) did not show any contamination. Sizes were 
compared to the loaded marker 
 
marker                         plasmid          donor vector            NTC 
bp
1353
1078 
872
603     
310
AdipoQ insert
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2.1.3. Analysis of the destination vector  
 
The precise insertion of AdipoQ gen in the destination vector was analyzed by restriction with 
HindIII and XbaI. The expected fragments had a length which equated to the AdipoQ insert 
(711 bp) plus 40 bp of the XbaI and/or HindIII restriction sites and the corresponding tag size. 
The expected fragment sizes are shown in Table 5. 
 
Table 5: Expected fragment sizes (restriction site + AdipoQ insert + tag size) of cloned destination 
vectors  
Vector IBA 4 adibos IBA 35 adibos IBA 25 adibos IBA 105 adibos 
N-terminal Tag 
Strep + signal 
sequence 
6 His GST One Strep 
restricted 
fragment sizes 
[bp] 
857 783 1404 855 
 
 
Fig. 22: Restriction analysis of all vectors, size-separated in a 1% agarose gel. Intact plasmid of IBA 4 
adibos was used as a control; sizes were compared to the loaded marker 
  
marker                C1        C2        C3        C4        C1      C2       C3      C4       C1       C2       C3       C4 C1        C2      C3      C4    plasmid
bp
1353
1078
872
603
310
IBA 4 adibos IBA 105 adibos IBA 35 adibos IBA 25 adibos
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2.2. Overexpression of the adiponectin protein in E. coli TOP10 cells  
 
2.2.1. Confirmation of adiponectin expression in different vectors  
 
Within all vectors, protein expression was highest after 4 h of incubation (Fig. 23). The size of 
the expressed AdipoQ varied according to the specific tag. The different sizes are given in 
Table 6.  
 
Table 6: Different expected sizes of expressed proteins 
Vektor IBA 4 adibos IBA 25 adibos IBA 35 adibos IBA 105 adibos 
Tag Strep GST 6 His One Strep 
Protein size 
[kDa] 
28 51 26 29 
 
The SDS-PAGE analysis was performed using pellets of the protein expression solution.  
 
 
Fig. 23: SDS-PAGE analysis of cell pellets of the overexpressed adiponectin in 4 different vectors. 
Circles indicate higher protein expression after 4 h at the vector-specific protein size 
  
kDa
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20
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IBA 4 adibos IBA 25 adibos IBA 35 adibos IBA 105 adibos
0h       4h          0h        4h         0h        4h         0h       4h 
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2.2.2. The appearance of adiponectin in different expression forms 
 
The results presented in Fig. 24 show that AdipoQ was expressed in the soluble form (IBA 
25-, 35-, 105 adibos) and in inclusion bodies (IBA 4 adibos). Protein expressed in the soluble 
form was found in the supernatant. If it was expressed in inclusion bodies, no bands were 
found in the supernatant. For further AdipoQ expression, IBA 35 adibos was used, since it 
had most of the expressed protein in the soluble form. 
 
 
Fig. 24: The expression pattern of AdipoQ in different vectors, verified by SDS Page and coomassie 
staining. Pellet (P) and the corresponding supernatant (S) from each vector, was loaded on a 12% 
Tris–Tricine gel 
 
 
2.3. Adiponectin purification with Ni-TED resin  
 
The sonicated supernatant of His-tagged protein was purified by affinity-binding to the Ni-
TED resin. The residual eluents showed bands at approximately 30 kDa and an additional one 
at around 55 kDa. These bands correspond to the sizes of the AdipoQ monomer and dimer 
(Fig. 25). 
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Fig. 25: SDS PAGE of flow through (Fth), washing step 1 and 2 (W1, W2) and 6 elution steps (E1- 
E6). Protein was non-specifically stained by silver staining. Protein sizes were estimated by compari-
son to the loaded marker 
 
Furthermore, the collected eluents were applied to Western blot with a specific antibody 
against His-tags. Herein, all eluents and the washing buffer and flow-through of the purifica-
tion showed signals for the His-tagged proteins (Fig. 26).  
 
 
Fig. 26: Western blot detection of purified AdipoQ detected with an anti His-tag antibody. Flow-
through (Fth), washing (W1) and eluents (E1- E6). 
Eluents with high protein content, i.e. E1- E6, were mixed and concentrated with Viva Spin Columns 
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The photometrically estimated concentration of protein solution was 0.7 mg/mL. The purified 
and concentrated protein was verified as bovine AdipoQ by mass spectrometry.  
The recombinant AdipoQ was detectable in Western blot with anti AdipoQ antibody (rab14) 
which was used for all Western blot and ELISA analyses. Recombinant AdipoQ was detected 
down to a concentration of 250 ng (Fig. 27). 
 
 
Fig. 27: Dilution series of recombinant AdipoQ analyzed by semi-native Western blot and detected 
with anti-bovine AdipoQ antibody. Molecular weight of the bands was estimated by comparison to the 
molecular weight marker 
 
With the use of the Stargate cloning procedure, we were able to express AdipoQ in E. coli 
linked with four different tags. The vector associated with the His-tag showed the highest ex-
pression level in the soluble form; therefore, we selected this vector with the His-tag to further 
proceed with the AdipoQ overexpression. His-tagged proteins are easy to purify from protein 
solution because of their high affinity to Ni ions. The ion affinity chromatography method 
used here is a commonly used method for the purification of His-tagged proteins (Waki et al., 
2003, Lichty et al., 2005). Because of the small size of the tag (0.8 kDa), it can be used with-
out affecting the biological function of the target protein (Lichty et al., 2005). 
One major limitation when expressing eukaryotic proteins in bacteria is their inability to post- 
translationally modify the expressed protein. In particular, the AdipoQ oligomers need to be 
extensively modified after translation; hydroxylation and glycosylation are necessary for the 
intracellular assembly of the oligomeric structures (Wang et al., 2008). Bacterially-generated 
recombinant AdipoQ lacking posttranslational modifications, such as lysine hydroxylation 
and glycosylation, can assemble into trimeric and hexameric forms, but not into HMW oligo-
mers (Tsao et al., 2003).  
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The Western blot detection of eluents with an anti-His-tag antibody yielded two major bands 
at about 30 and 50 kDa; these bands correspond to the AdipoQ monomer and dimer MW 
(Waki et al., 2003). Furthermore, the detection of untreated recombinant purified AdipoQ 
with the rab14 antibody, which was previously used in all Western blot procedures, resulted 
in two signals: a 30 kDa band and an 18 kDa band. These bands are in line with the AdipoQ 
monomer (Waki et al., 2003) and with the globular domain of AdipoQ (Waki et al., 2005). 
Recently, the globular domain of AdipoQ has also been described in purified bovine AdipoQ 
detected with the same antibody (rab14) (Mielenz et al., 2013).  
 
2.4. Endotoxin contamination  
 
A further challenge of protein expression in bacteria, especially in gram-negative bacteria, is 
the potential contamination of the protein solution obtained with lipopolysaccharides (LPS). 
For that reason, we applied our protein solution to an endotoxin removal procedure. However, 
the commercial LAL test which was used did not yield stable results. Therefore, we repeated-
ly assessed the concentration (three times) in the protein solution after applying it to the endo-
toxin removal resin and used the calculated mean of 27 EU/mL. This corresponds to an LPS 
concentration of 0.5 ng/mL in 20 µg AdipoQ/mL, and 1.6 ng LPS/mL in 60 µg AdipoQ/mL.  
The major challenge with LPS measurement in an LAL test is to avoid any contamination by 
lab instruments (pipette, tip, or 96-well plate). LPS is able to bind to plastic surfaces (Wiuff et 
al., 2000), which may explain the high variability in the amount of LPS detected in sample. 
All tubes used for standards and samples were pyrogen free, but the possibility that LPS in the 
sample binds to the plastic cannot be excluded. However, this would be an advantage for cell 
culture experiments, since the probability that LPS would interfere with the cells is thereby 
reduced. 
Additionally, the temperature has an impact on performance of the test and the vortexing and 
mixing procedure of standards may also influence the repeatability of the LAL test. Blechova 
and Pivdova (2001) tested the LAL test as an alternative for pyrogen tests in rabbits. As nega-
tive points of the LAL test, they mentioned that slight disturbances influence the outcome of 
the test. 
Adiponectin is able to bind LPS (Peake et al., 2006). The authors describe the binding of LPS 
and native AdipoQ (isolated from human serum).  
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Furthermore, they estimated a bond between HMW recombinant AdipoQ and LPS that was 
abolished if reduced to trimers and if deglycosylated. The recombinant AdipoQ purified from 
E. coli is not glycosylated (Wang et al., 2004), which indicates that our recombinant bovine 
AdipoQ will not bind to LPS.  
In general, LPS affected lymphocyte proliferation. Activation of immune cells by LPS is me-
diated by the cell surface protein CD14 (Wright et al., 1990), which is mainly expressed on 
monocytes, polymorphonuclear leukocytes and on some B-lymphocytes (Heine et al., 2001), 
as well as the Toll like receptor 4 (TLR4). The TLR4 generates an innate immune response 
following LPS stimulation (Poltorak et al., 1998). A study showed that human T-cells respond 
to LPS mediated by TLR4; LPS up-regulated the T-cell adherence to fibronectin and down-
regulated the chemotaxis (Zanin-Zhorov et al., 2007). Additionally, T-lymphocytes are acti-
vated by LPS, but their activation depends on accessory monocytes providing co-stimulatory 
signals (Mattern et al., 1998). However, this kind of stimulation is minimized in our in vitro 
tests, because of the separation of monocytes from PMBCs. 
For our in vitro functional test we mainly focused on lymphocytes, due to the high reactivity 
of monocytes and granulocytes to LPS stimulation. 
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2.5. Immunological test 
 
2.5.1. Isolation of peripheral mononuclear cells  
 
Density gradient flow centrifugation lead to a good separation of PBMC from whole blood. 
Flow cytometric scatter plots showed only monocytes and lymphocytes after centrifugation 
(Fig. 28).  
 
 
Fig. 28: Scatter plots of whole blood (A) in comparison to PBMCs (B) isolated by density gradient 
centrifugation (SSC-H: side scatter, FSC-H: forward scatter)  
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2.5.2. Isolation of monocytes and lymphocytes  
 
The separation of monocytes and lymphocytes by plastic adherence led to 78% pure lympho-
cytes of all gated cells and 80% monocytes in all gated cells, respectively (Fig. 29). 
A 
 
B 
 
 
Fig. 29: Scatter plots of isolated lymphocytes (A) and monocytes (B). Cells were gated in relation to 
their cell size and granularity, R1 is the region for lymphocytes and R2 shows the monocytes. Ungated 
cells were mainly cell debris or dead cells 
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2.5.3. Isolation of granulocytes 
 
Granulocytes from the cell pellet after density gradient centrifugation were isolated by repeat-
ed erythrocyte lyses. The scatter plot of isolated granulocytes showed a high contamination 
with monocytes (Fig. 30). In gate R2, 59% of monocytes were gated and in R1 there were still 
12% of lymphocytes detected.  
 
Fig. 30: Scatter plot of isolated granulocytes. Gated cells in R1 were lymphocytes and in R2 mono-
cytes 
 
The separation of monocytes and lymphocytes out of PBMCs by adherence resulted in good 
purity of the cells. We could not reach the purity of monocytes described in the method that 
we applied (Dörffel et al., 1999), which might have been partly due to the method used to 
assess purity. Dörffel et al. (1999) used monocyte-specific antibodies to detect monocytes, 
while we applied the cell solution to flow cytometry without any specific antibody. Also, the 
isolation of granulocytes described by Siemsen et al. (2007) differed from ours, which might 
explain the contamination in isolated granulocytes. After the lysis of erythrocytes, we did not 
apply the residual cell suspension to a density gradient (Siemsen et al., 2007). As we decided 
to use lymphocytes for the functional test, we did not continue with the optimization of granu-
locyte isolation.  
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2.6. Lymphocyte proliferation test 
 
2.6.1. Influence of lipopolysaccharide (LPS) contamination on lymphocyte proliferation 
 
Lymphocytes stimulated with ConA and LPS at the same time had decreasing stimulation 
index values with increasing LPS concentrations. The LPS concentrations corresponding to 
the concentrations estimated in the recombinant AdipoQ preparation decreased the stimula-
tion index. A 20% decrease in stimulation was observed at an LPS concentration of 0.4 ng/mL 
and with an LPS concentration of 1.6 ng/mL, the stimulation was reduced by 26% in compari-
son to unstimulated cells. 
Lymphocytes treated with LPS in concentrations from 0.4 ng up to 100 µg, but without ConA, 
showed no differences in proliferation.  
  
2.6.2. Effects of recombinant bovine adiponectin on lymphocyte proliferation  
 
The stimulation with 20 and 60 µg/mL AdipoQ decreased lymphocyte proliferation. At 20 
µg/mL, the stimulation index was 61% of AdipoQ-free controls (P = 0.102) and 60 µg/mL 
reduced the stimulation index (P < 0.05) to 49% (Fig. 31).  
 
 
Fig. 31: Stimulation index of lymphocytes incubated with or without 20 or 60 µg/mL recombinant 
bovine adiponectin (means ± SEM; n=6); different letters indicate significant differences (P ≤ 0.05). 
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Decreasing lymphocyte proliferation was observed with increasing AdipoQ concentrations. 
The AdipoQ concentrations used here mirrored the serum concentration at parturition (20 
µg/mL) and a very high, but still physiological concentration (60 µg/mL) observed in individ-
ual cows at mid-lactation (Mielenz et al., 2013). Ahmed et al. (2008) observed that leptin, 
another important adipokine, exerts a dose-dependent suppression of anti-CD3-induced pro-
liferation of bovine T lymphocytes. Both AdipoQ receptors were estimated by flow cytometry 
on human immune cell surfaces; the highest expression level, at about 90% of the cells, was 
found on monocytes, whereas only 10% of lymphocyte subpopulations expressed AdipoRs on 
their cell surface (Wilk et al., 2011). Additionally, the low AdipoR expression at the cell 
membrane was explained by the finding that T-cells express AdipoRs intracellularly and 
AdipoRs are translocated to the cell surface upon antigen-specific stimulation (Wilk et al., 
2011). The stimulation of a human T-lymphocyte cell line by AdipoQ (10 µM) did not affect 
its proliferation ability, but a decrease in the secretion of proinflammatory cytokines was de-
tected (Takahashi et al., 2010). These results indicate that AdipoQ might be involved in im-
mune suppression. However, in view of the increasing AdipoQ concentrations and the nor-
malized lymphocyte activity at later stages of lactation, factors other than AdipoQ are proba-
bly more important for regulating lymphocyte proliferation. In addition, the lymphocyte 
prolifertion might also be influcende due to the LPS contained in the recombinant AdipoQ 
prepration. 
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Adiponectin is mainly secreted by adipocytes and occurs in the circulation in different MW 
forms as a result of several post-translational modifications (Wang et al., 2008). Herein, we 
demonstrated that AdipoQ occurs in different MW patterns in different body fluids, whereas it 
seems that the physiological state and concentration in different fluids does not influence the 
MW secretion pattern of AdipoQ in cattle. The focus of the present discussion is on aspects of 
AdipoQ secretion which were not previously mentioned in the chapters or manuscript. 
The secretion of AdipoQ oligomers is tightly regulated by molecular chaperones in the endo-
plasmic reticulum, namely ERp44 (an ER protein of 44 kDa) and DsbA-L (a disulfide-bond A 
oxidoreductase-like protein) and the oxidoreductase Ero1-Lα (ER oxidoreductase 1-Lα) 
(Wang et al., 2008; Liu et a., 2008). Adiponectin binds to ERp44, which causes the thiol-
mediated retention of AdipoQ and inhibits secretion (Wang et al., 2008). Ero1-Lα is ubiqui-
tously expressed and is thought to be the rate-limiting step in disulfide bond formation in 
most cell types (Cabibbo et al., 2000); it further promotes the release of AdipoQ from ERp44 
(Wang et al., 2007). DsbA-L also binds AdipoQ and is involved in regulating the AdipoQ 
disulfide bond formation. However, it was not able to form AdipoQ multimers when AdipoQ 
was incubated alone with DsbA-L (Liu et al., 2008).  
Not only is the pattern of AdipoQ secretion influenced by chaperones, but also the total 
amount might be regulated. Treatment of mice with PPARγ agonists lead not only to in-
creased AdipoQ serum concentrations, but also increased the expression of ERp44 and Ero1-
Lα in AT, which identifies the two chaperones as possible targets for PPARγ agonist action 
(Wang et al., 2007). PPARγ expression in AT of dairy cows was lowest at parturition and 
increased during the course of lactation (Saremi et al., 2014). We found a similar profile of 
AdipoQ serum concentrations during the first weeks of lactation. PPARγ is a key regulator of 
insulin sensitivity and adipogenesis (Rosen and MacDougald, 2006) and is related to AdipoQ 
secretion. A previous study demonstrated that insulin treatment influences the AdipoQ ERp44 
interaction; the increase in AdipoQ resulted from a decreasing affinity between AdipoQ and 
Erp44, which resulted in the direct secretion of AdipoQ by ER as a trimer (Wang et al., 2007). 
Once released by adipocytes, the complex distribution of AdipoQ MW forms seems to be 
stable. Repeated freezing and thawing of human serum samples did not influence the MW 
distribution (Schraw et al., 2008). We also confirmed findings with bovine serum assayed by 
semi-quantitative Western blot and ELISA. 
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Additionally, in vitro studies showed that HMW AdipoQ can be spontaneously formed 
through the aggregation of smaller oligomers (Briggs et al., 2009). These findings might be 
beneficial in states of decreased HMW AdipoQ, e.g. insulin resistance, in which either ab-
normalities in the oxidation processes in the ER or decreased numbers of chaperones occur 
(Briggs et al., 2009).  
The pH is another important parameter for AdipoQ stability; it was found that human AdipoQ 
is very sensitive to pH changes between 6 and 7, whereas the MW forms of mice AdipoQ 
were unaffected by variations in pH: with decreasing pH, the HMW complexes were degrad-
ed to MMW and trimers (Schraw et al., 2008). 
The AdipoQ MW patterns might also be influenced by enzyme degradation. Waki et al. 
(2005) showed via in vitro experiments that the cleavage of AdipoQ into fragments (25, 20 
and 18 kDa) is mediated by a protease. The enzyme secreted by a human monocyte cell line 
cleaves AdipoQ into the smallest form of AdipoQ, the globular domain (18 kDa). As globular 
AdipoQ is known for its different biological activity compared to full length AdipoQ (Waki et 
al., 2003), it raises the possibility that the activity of AdipoQ might be modulated by the 
cleavage (Waki et al., 2005). 
Human serum samples treated with EDTA had lower amounts of HWM AdipoQ compared to 
untreated serum. Furthermore, the addition of calcium to human plasma samples increased the 
formation of HMW AdipoQ complexes (Banga et al., 2008). Likewise, the binding human of 
AdipoQ to LPS was calcium-dependent, as described by Peak et al. (2006); they reported an 
increase of AdipoQ binding to LPS by treatment with EDTA and EGTA, whereas the addition 
of calcium inhibited the binding.  
Taken together, many factors are described to affect the MW patterns of AdipoQ, either be-
fore or after secretion. Generally, differences in AdipoQ MW patterns might also be related to 
the different detection systems used in several studies. 
In conclusion, further estimation of the AdipoQ MW pattern is reasonable to identify possible 
factors influencing the expression patterns of AdipoQ. Altogether, the concentration and MW 
patterns of AdipoQ are important to elucidate the functional role of AdipoQ in livestock, in 
particular in dairy cows. 
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Summary  
 
Adiponectin is one of the most abundant adipokines in circulation. It is secreted by adipocytes 
in three different molecular weight (MW) forms: a trimer with low molecular weight (LMW), 
a hexamer with middle molecular weight (MMW) and as a multimeric high molecular weight 
(HMW) form consisting of 12-18 monomers. Adiponectin is negatively correlated with body 
fat content and is known to be a key regulator of insulin sensitivity and tissue inflammation. 
Dairy cows undergo various metabolic changes in the time from late pregnancy to early lacta-
tion. The energy demand for milk production cannot be covered by feed intake, which results 
in a negative energy balance. Mobilizing body fat as an energy source may lead to impaired 
immune function and a higher risk of infectious diseases. The health status of the cow has a 
strong influence on fertility. 
Due to a lack of species-specific assays, estimating AdipoQ concentrations or the MW pattern 
was impeded; therefore, this thesis aimed (1) to establish a semi-quantitative Western blot to 
investigate AdipoQ concentrations in the serum and milk of lactating dairy cows, (2) to de-
velop a semi-native Western blot to characterize the AdipoQ MW patterns in several body 
fluids at different physiological stages of cows and bulls, and (3) to investigate the effect of 
recombinant AdipoQ on lymphocyte proliferation. 
After validation of the semi-quantitative Western blot by establishing the linearity and repro-
ducibility, the AdipoQ serum concentrations throughout lactation were estimated. Blood sam-
ples of six multiparous Holstein cows were collected from day -21 to day 252 relative to calv-
ing. The serum AdipoQ concentrations decreased towards parturition, reaching a nadir at day 
-7 and increased after parturition again until relatively constant levels were attained, begin-
ning at day 21. The decreasing AdipoQ serum concentrations around parturition may enhance 
gluconeogenesis and improve glucose uptake into the mammary gland for milk production. 
The semi-quantitative Western blot was also used to characterize AdipoQ concentration in 
milk samples from three multiparous dairy cows collected from day 5 until day 21 in lacta-
tion. The AdipoQ concentration in milk slightly decreased throughout the first three weeks. 
The concentration at day 5 in lactation was 2-fold higher compared to the concentrations at 
day 8 and 11 in lactation. Decreasing milk AdipoQ concentration could be explained by the 
rapid changes of milk composition in the first weeks of lactation. 
The semi-native Western blot was also validated by linearity and demonstration of the bands 
expected after reducing, denaturing treatment.  
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Afterwards, it was applied for investigation of the AdipoQ MW patterns in serum samples of 
four lactating Holstein cows (two multiparous and two primiparous). Sampling 1 day post-
partum (p.p.) and 105 days p.p. were selected, as AdipoQ serum concentrations on these days 
were significantly different. The MW patterns showed no differences, either between days or 
parity. The changes in blood hormones and metabolites thus rather result in altered AdipoQ 
concentrations, but not in shifts of the MW pattern.  
To define the MW pattern of AdipoQ in milk in early lactation, milk samples from three mul-
tiparous Holstein dairy cows were used. Milk samples were collected three times a week at 
the morning milking beginning from day 5 p.p. until day 21 p.p. The AdipoQ MW patterns in 
mature milk were apparently not different to those seen previously in serum. The given simi-
larity of serum and milk AdipoQ MW patterns might indicate that milk AdipoQ arises from 
the circulation into the mammary gland.  
We estimated the MW pattern and concentration of AdipoQ in cerebrospinal fluid (CSF) and 
the serum of dairy cows in the transition period. For that purpose, CSF and the corresponding 
serum samples were collected from ten German Holstein dairy cows at different days in the 
transition period. The MW patterns of AdipoQ in CSF and serum samples of individual days 
in the transition period showed no apparent differences. The MMW band was the most prom-
inent one in all cases, whereas the HMW tented to be faint in all samples, independent of 
whether the sample was serum or CSF. Furthermore, the MW pattern in serum or CSF did not 
differ for the different stages of the transition period. The transfer of AdipoQ through the 
blood brain barrier might explain the similarity of the MW pattern found in serum and CSF. 
A further aim was to investigate AdipoQ patterns in cattle, other than Bos taurus. Blood sam-
ples from Yak (Bos grunniens), American Bison (Bison bison) and blood and milk samples 
from Water buffalo (Bubalus bubalis) were collected. Semi-native Western blot analysis of 
blood and milk samples yielded signals in all samples. The MW patterns of AdipoQ in Yak, 
Bison, Water buffalo and buffalo milk were mostly the same. In all samples, a prominent 
MMW band (~ 130 kDa) and HMW band (> 250 kDa) were detected. In general, the MW 
pattern was comparable to the pattern seen before in serum and milk of Bos taurus. The miss-
ing differences in AdipoQ MW pattern within Bovidae might indicate that the MMW form of 
AdipoQ is the most abundant in cattle.  
To characterize the potential effects of experimentally-induced mastitis on AdipoQ MW pat-
terns, milk and serum samples of seven mid-lactating cows were estimated. One quarter per 
udder was experimentally infused with lipopolysaccharides (LPS). For Western blot analysis, 
serum and milk samples, before and eight hours after LPS challenge, were used.  
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The distribution of AdipoQ MW complexes did not vary between before and after LPS chal-
lenge, neither in serum samples nor in milk samples. It seems that experimentally-induced 
mastitis with LPS does not change the secretion pattern of AdipoQ, which additionally sup-
ports that milk AdipoQ arises from the circulation. 
To characterize the MW patterns of AdipoQ in different adipose tissue (AT) depots, homoge-
nates from visceral (mesenterial, omental, retroperitoneal) and subcutaneous (sc.) (withers, 
sternum, tail head) AT and from the mammary gland were used. For that purpose, AT and 
mammary gland homogenates from three different days (1, 42 and 105) in lactation were 
used. Different AT and mammary gland homogenates showed no differences in the MW-
pattern of AdipoQ. In each sample, a HMW and a MMW band was detectable, independent of 
the stage of lactation. Changes in AdipoQ serum concentrations during lactation might not be 
reflected in changes in the MW patterns of AdipoQ in bovine AT. The similarity of mammary 
gland AdipoQ MW patterns to serum AdipoQ MW may indicate that AdipoQ from the serum 
is mainly present in the mammary gland homogenate. 
Additionally, the AdipoQ concentration and pattern in allantoic fluid (AF), and maternal 
blood samples collected at cesarean sections from four Holstein heifers were estimated. The 
AdipoQ concentrations of cows were well within the expected range and pattern seen for par-
turition. In AF, only 0.01% of maternal serum concentration was found. The MW pattern of 
AdipoQ found in AF was mainly HMW. These findings indicate that the AF AdipoQ might 
be of fetal origin, whereas the maternal serum pattern did not vary in the studied cows previ-
ously.  
A further study was carried out to characterize AdipoQ in bovine body fluids related to repro-
duction. For that purpose, we used seminal plasma (SP) from 29 Holstein breeding bulls and 
follicular fluid (FF) from 14 Simmental heifers. Additionally, we collected blood samples 
corresponding to the respective reproductive fluid throughout the estrous cycle. The SP 
AdipoQ concentrations were 180- fold lower compared to serum concentrations. The correla-
tion (r = 0.843, p < 0.01) between both fluids indicates the origin of SP AdipoQ in circulation. 
Both fluids had the HMW and the MMW form of AdipoQ, with the HMW form of AdipoQ 
being more abundant in SP than in serum. Another finding of this study was the age-
dependent increase of AdipoQ concentration in serum and SP. Increasing AdipoQ concentra-
tions with age might be due to a reduction in sex hormones, which possibly influence AdipoQ 
secretion.  
The AdipoQ concentrations in FF were 1.6-fold lower than the corresponding serum concen-
trations and the MW forms were different compared to serum.  
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Since only MMW AdipoQ was detected in FF, we assume that it is locally produced and does 
not completely originate from the circulation. In serum samples collected across the estrous 
cycle, a variation (P < 0.01) over time was observed. The lowest serum concentration in es-
trous was found at day 10, which might be in relation to increasing progesterone concentra-
tions during these days. Another finding of this study was the sexual dimorphism which has 
been described earlier in human and rodent studies. Bulls had lower AdipoQ serum concentra-
tions compared to heifers, whereas no differences were seen in the MW patterns.  
In a further experiment, we investigated the effect of bovine recombinant AdipoQ on lympho-
cyte proliferation. Adiponectin was expressed as an NH2-terminal (his)6-tagged fusion protein 
in E. coli Top 10 strain. Blood was collected from six mid-lactating (100 days ± 7 post-
partum) Holstein cows by jugular vein puncture. Lymphocytes were isolated by density gradi-
ent centrifugation and subsequent separation was performed by adherence on cell culture 
dishes. Proliferation of lymphocytes was stimulated by the mitogen Concanavalin A (10 
µg/mL) and analyzed by the colorimetric MTT (dimethylthiazol) assay. To estimate the mito-
gen-stimulated proliferation rate, 1× 10
6
 lymphocytes/mL medium were incubated with two 
different concentrations of AdipoQ, 20 and 60 µg/mL. Both AdipoQ concentrations decreased 
lymphocyte proliferation, with the 60µg/ml concentration having a stronger effect than the 20 
µg/mL concentration. We concluded that AdipoQ might be involved in immune suppression. 
However, in view of the increasing AdipoQ concentrations and the normalized lymphocyte 
activity at later stages of lactation, factors other than AdipoQ are probably more important for 
regulating lymphocyte proliferation. In addition, a possible influence of LPS out of the recombi-
nant AdipoQ-solution might influence the proliferation of lymphocytes. 
The results of this thesis provide AdipoQ profiles in several bovine body fluids. Further esti-
mation of AdipoQ MW pattern is reasonable to identify possible factors influencing the ex-
pression patterns of AdipoQ. Altogether, the concentration and MW patterns of AdipoQ are 
important to elucidate the functional role of AdipoQ in livestock, in particular in dairy cows. 
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Zusammenfassung 
 
Adiponektin (AdipoQ) ist eines der am häufigsten in der Zirkulation vorkommenden Adipo-
kine. Es beeinflusst verschiedene metabolische Prozesse, trägt zur Verbesserung der 
Insulinsensitiviät bei und mildert Entzündungen im Gewebe. Die Sekretion erfolgt in drei 
unterschiedlichen Molekulargewichtsformen (MW): als Trimer in der niedermolekularen 
Form (LMW), als Hexamer in der mittleren Molekularform (MMW), sowie als multimere 
hochmolekulare Form (HMW), bestehend aus 12-18 Monomeren. Milchkühe sind in der Zeit 
der späten Trächtigkeit und frühen Laktation vielen metabolischen Veränderungen ausgesetzt. 
Die für die Milchproduktion benötigte Energie kann nicht durch die Futteraufnahme gedeckt 
werden und führt zu einer negativen Energiebilanz. Dies wiederum resultiert in einer Mobili-
sierung von Körperreserven, welche zu einem erhöhten Risiko für Infektionskrankheiten füh-
ren kann und möglicherweise auch die spätere Fortpflanzungsleistung beeinflusst.  
Auf Grund fehlender speziesspezifischer Assays waren Untersuchungen zu AdipoQ auf Prote-
inebene beim Rind nur sehr eingeschränkt möglich. Ziel dieser Arbeit war deshalb (1) die 
Etablierung eines semi-quantitativen Western Blots zur Bestimmung der AdipoQ-
Konzentration in Serum und Milch von Milchkühen im geburtsnahen Zeitraum, (2) die Ent-
wicklung eines semi-nativen Western Blots, zur Charakterisierung unterschiedlicher MW von 
AdipoQ in verschiedenen Köperflüssigkeiten und Geweben und (3) die Untersuchung mögli-
cher Auswirkungen von rekombinanten AdipoQ auf die Funktionsfähigkeit von Lymphozy-
ten. 
Nach der Validierung des semi-quantitativen Western Blots an Hand der Bestimmung der 
Linearität und Reproduzierbarkeit wurden die AdipoQ-Serumkonzentrationen im geburtsna-
hen Zeitraum und über die Laktation bestimmt. Dazu wurden Serumproben von sechs multi-
paren Holstein-Kühen von Tag -21 bis Tag 252 relativ zur Geburt entnommen. Die Serum-
AdipoQ-Konzentrationen sanken in Richtung Geburt und wiesen die niedrigsten Konzentrati-
onen am Tag -7 auf. Nach der Geburt stiegen sie wieder an und verblieben ab Tag 21 auf ei-
nem relativ konstanten Niveau. 
Die verringerten AdipoQ-Konzentrationen bis zur Geburt könnten die Glukoneogenese sowie 
die Glukoseaufnahme der Milchdrüse zur Milchproduktion verbessern. Ergänzende Analysen 
wurden an Milchproben von drei multiparen Milchkühen durchgeführt. Hierzu wurden 
Milchproben von Tag 5 bis Tag 21 der Laktation gesammelt. Die AdipoQ-Konzentration in 
Milch war am Tag 5 der Laktation doppelt so hoch wie an Tag 8 und Tag 11. 
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Sinkende AdipoQ-Konzentration in der Milch könnten mit der schnellen Veränderung der 
Milchzusammensetzung in diesem Zeitraum zusammen hängen.  
Der semi-native Western Blot wurde durch Nachweis der Linearität und durch Demonstration 
der zu erwartenden Banden nach reduzierender und denaturierender Behandlung validiert. 
Anschließend wurde die Methode für die Bestimmung des AdipoQ-MW-Profils in Serumpro-
ben von vier laktierenden Holstein-Kühen (zwei multipare, zwei primipare) verwendet. Auf 
Grund der signifikanten Unterschiede in der AdipoQ-Serumkonzentration an Tag 1 und Tag 
105 post partum (p.p.) wurden diese Tage zur Bestimmung der MW-Profile verwendet. Die 
MW-Profile zeigten keine Unterschiede zwischen den Tagen nach der Kalbung. Die auftre-
tenden Schwankungen in den Bluthormon- und Metabolitenkonzentrationen resultieren zwar 
in einer Veränderung der Serumkonzentration, aber beeinflussen offenbar nicht das MW-
Profil.  
Weiterhin wurde das AdipoQ-MW-Profil in der Milch von drei multiparen Holstein-Kühen 
ermittelt. Dazu wurden Milchproben bei der morgendlichen Melkung 3-mal wöchentlich von 
Tag 5 bis Tag 21 in der Laktation gesammelt. Die MW in der Milch waren augenscheinlich 
nicht unterschiedlich zu den MW im Serum. Die Ähnlichkeit des MW-Profils in Serum und 
Milch deutet darauf hin, dass das AdipoQ in der Milch aus der Zirkulation stammt.  
Außerdem wurde das AdipoQ-MW-Profil und die Konzentration in Cerebrospinalflüssigkeit 
(CSF) von Kühen in der Transitionsperiode bestimmt. Dazu wurden CSF- und Blutproben 
von zehn Deutschen Holstein Kühen an unterschiedlichen Tagen der Transitionsperiode ge-
sammelt. Das MW Profil in CSF und Serum zeigte zu unterschiedlichen Zeitpunkten in der 
Transitionsperiode keine offensichtlichen Unterschiede. Die MMW-Form von AdipoQ war zu 
allen Zeitpunkten die am häufigsten vorkommende, wohingegen HMW-AdipoQ als schwache 
Bande zu detektieren war im Serum gleichermaßen wie in CSF. Außerdem hatte auch der 
Zeitpunkt in der Transitionperiode keine Auswirkungen auf der Verteilung der MW-Formen, 
weder in den Serum- noch in den CSF-Proben. Adiponektin könnte über die Blut-Hirn-
Schranke in das CSF gelangen, was die Ähnlichkeit des MW-Profils zum Serum erklären 
würde.  
Ein weiteres Ziel war die Untersuchg der AdipoQ-Profile in artverwandten Spezies der Rinder 
(Yak, Bison, Wasserbüffel). Blutproben von Yak (Bos grunniens) und amerikanischem Bison 
(Bison bison) und Milch- und Blutproben von Wasserbüffeln (Bubalus bubalis) wurden ge-
sammelt. Mittels semi-nativer Western Blot Analyse konnte für alle Proben ein Profil der 
AdipoQ-MW-Formen erstellt werden. Alle drei Spezies zeigten dasselbe AdipoQ Profil; die 
MMW Bande war die intensivste und die HMW Bande war bei allen sichtbar.  
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Generell was das MW-Profil vergleichbar mit dem in Serum und Milch vom Hausrind der 
Gattung Bos Taurus. Die fehlenden Unterschiede in der MW-Verteilung von AdipoQ zwi-
schen den Spezies deuten darauf hin, dass die MMW Form von AdipoQ die am meisten vor-
kommende im Rind sein könnte.  
Um den Einfluss einer experimentell hervorgerufenen Mastitis auf das AdipoQ-MW-Profil zu 
charakterisieren, wurden Milch- und Serumproben von sieben Kühen in der mittleren Laktati-
on untersucht. In je ein Euterviertel der Kühe wurden Lipopolysaccharide (LPS) infundiert. 
Zur Analyse im semi-nativen Western Blot wurden Milchproben aus dem behandelten 
Euterviertel und Serumproben vor und acht Stunden nach der LPS-Infusion verwendet. Die 
Verteilung der AdipoQ MW-Komplexe zeigte keine Unterschiede vor oder nach der LPS In-
fusion, weder in Serum noch in Milchproben. Vermutlich wird die AdipoQ-Sekretion nicht 
durch eine experimentell induzierte Mastitis beeinflusst, was wiederum dafür spricht, dass das 
in der Milch vorhandene AdipoQ aus dem Blut stammt. 
Zur Charakterisierung des AdipoQ-MW-Profils in verschiedenen Fettgeweben (AT) wurden 
Homogenate aus visceralem (vc.) (mesenterial, omental und retroperitoneal) und subcutanem 
(sc.) (Widerrist, Brustbein und Schwanzansatz) Fettgewebe und von Eutergewebe verwendet. 
Zur Analyse im semi-nativen Western Blot wurden Fett- und Euterhomogenate von drei ver-
schiedenen Tagen in der Laktation (1, 42 und 105) verwendet. Es wurden keine Unterschiede 
in der Verteilung der AdipoQ MW-Formen in den unterschiedlichen Geweben detektiert. In 
jeder Probe wurde eine HMW- und eine MMW-Bande, unabhängig vom Zeitpunkt in der 
Laktation, gezeigt. Veränderungen der AdipoQ-Serumkonzentrationen in diesem Zeitraum 
werden vermutlich nicht im AdipoQ MW-Profil in den verschiedenen AT und dem 
Eutergewebe wiedergespiegelt. Die Ähnlichkeit des MW-Profils von AdipoQ zum Serumpro-
fil deutet darauf hin, dass das detektierte AdipoQ im Euter aus der Zirkulation stammt.  
Des Weiteren wurde die AdipoQ-Konzentration, sowie das MW-Profil in Fruchtwasser (Al-
lantois Flüssigkeit, AF) und dem korrespondierenden maternalen Serum von vier deutschen 
Holstein Färsen bestimmt. Die AdipoQ-Serumkonzentration der Kühe lag im erwarteten Kon-
zentrationsspektrum zum Zeitpunkt der Geburt. In AF wurden nur 0,01% der maternalen Se-
rumkonzentration gefunden. Das AdipoQ-MW-Profil in AF wies hauptsächlich HMW-
Banden auf. Diese Ergebnisse deuten auf einen fetalen Ursprung des in AF gefundenen 
AdipoQs hin. Die MW-Profile des maternalen Serums entprachen denen der zuvor untersuch-
ten Serumproben der Kühe. 
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Ein weiterer Bestandteil dieser Arbeit war die Charakterisierung von AdipoQ in bovinen Kör-
perflüssigkeiten in Bezug zu Reproduktion. Hierzu wurde Seminalplasma (SP) von 29 Hol-
steinzuchtbullen und Follikelflüssigkeit (FF) von 14 Simmental-Färsen gesammelt. Zu jeder 
Flüssigkeit wurden korrespondierende Serumproben während des Östruszyklus gewonnen. 
Die AdipoQ-Konzentration der SP Proben zeigten 180- fach niedrigere Werte als die der kor-
respondieren Serumproben. Die Korrelation der beiden Flüssigkeiten deutet auf einen Trans-
fer vom Blut in SP hin. Beide Flüssigkeiten zeigten HMW- und MMW- AdipoQ- Formen, 
wobei in SP mehr HMW als in Serum zu finden war. Ein weiteres Ergebnis dieser Untersu-
chung war ein altersbedingter Anstieg der AdipoQ-Konzentration in Serum und SP. Anstei-
gende AdipoQ Konzentration im Alter könnten durch die im Alter reduzierten Sexualhor-
monkonzentrationen erklärt werden. 
In der FF war 60% der AdipoQ Konzetration des korrespondierenden Serums zu finden. Auch 
das MW-Profil zeigte Unterschiede. Dass nur MMW AdipoQ in FF detektiert wurde, lässt 
vermuten, dass es auch lokal produziert wird und nicht ausschließlich aus der Zirkulation 
stammt. In Serumproben aus dem Verlauf des Östuszyklus wurden Schwankungen (P < 0.01) 
in der AdipoQ-Konzentration ermittelt. An Tag 10 im Zyklus wurden die niedrigsten AdipoQ-
Serumkonzentrationen ermittelt. Sie könnten im Zusammenhang mit steigenden 
Progesteronkonzentrationen in diesem Zeitraum stehen. 
Ein weiteres Ergebnis dieser Untersuchung war ein Sexualdimorphismus der AdipoQ-
Serumkonzentration: Bullen hatten niedrigere AdipoQ-Konzentrationen im Vergleich zu Fär-
sen, wohingegen kein Unterschied bei den MW-Profilen gefunden wurde. 
In einem weiteren Experiment wurde der Effekt von rekombinantem bovinem AdipoQ auf die 
Lymphozytenproliferation ermittelt. Dazu wurde Adiponektin als NH2-Terminales (his)6 mar-
kiertes Fusionsprotein in Escherichia coli exprimiert. Blutproben zur Gewinnung von Lym-
phozyten wurden von sechs Holstein-Kühen in der Mitte der Laktation (Tag 100 ± 7) gesam-
melt. Die Lymphozyten wurden mittels Dichtegradientenzentrifugation und einer anschlie-
ßenden Plastikadherenz separiert. Die Proliferation der Lymphozyten wurde durch das Mito-
gen Concanavalin A (Con A, 10 µg/mL) stimuliert und mittels eines kolorimetrischen Tests 
analysiert. Um die mitogen-stimulierte Proliferationsrate zu bestimmen, wurden 1× 10
6 
Lym-
phozyten/mL Medium mit zwei unterschiedlichen AdipoQ-Konzentrationen, 20 und 
60µg/mL, inkubiert. Beide AdipoQ-Konzentrationen führten zu einer reduzierten 
Lymphozytenproliferation, wobei die Proliferation bei 60 µg/mL stärker reduziert war als bei 
20 µg/mL. 
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Dies lässt darauf schließen, dass AdipoQ in Immunsuppressionen involviert sein könnte, 
wenn man jedoch die steigenden AdipoQ-Konzentrationen und die wieder normalisierte 
Lymphozytenfunktion im Verlauf der späteren Laktation in Betracht zieht, sind möglicher-
weise andere Faktoren wichtiger als AdipoQ in der Regulation der Lymphozytenproliferation. 
Zudem kommt ein möglicher Einfluss von LPS aus der rekombinanten AdipoQ-Präparartion, 
der auch Einfluss auf die Proliferation der Lyphozyten gehabt haben könnte. 
Die Ergebnisse der vorliegenden Arbeit zeigen AdipoQ- MW-Profile in verschiedensten bo-
vinen Körperflüssigkeiten. Die Bestimmung der MW-Profile von AdipoQ wird weiterhin von 
Nutzen sein, um unterschiedlichste Faktoren, die das AdipoQ-Profil beeinflussen könnten, zu 
identifizieren. Um die funktionale Rolle von AdipoQ in Nutztieren, vor allem in Milchkühen 
aufzuklären, ist es weiterhin wichtig, die Konzentration und das MW-Profil von AdipoQ ge-
meinsam zu bestimmen. 
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Appendix A: Buffers, chemicals and solutions 
1. Western blot buffer:  
 
Resolving buffer 
1.5 M Tris (hydroxymethyl aminomethane)/HCl   (Carl Roth, Karlsruhe, Germany) 
0.4% SDS (Sodium dodecyl sulfate)     (Sigma Aldrich, St. Luis MO, USA) 
pH 8.8 
 
Stacking buffer 
0.5 M Tris/HCl 
0.4% SDS 
pH 6.8 
 
Resolving gel (8 %)/ (12 %) (2 Gels)  
2.7 mL / 4 mL Acrylamide (30%) (Rotiphorese® Gel A)  (Carl Roth) 
1.1 mL / 1.6 mL Bisacrylamide (2%) (Rotiphorese® Gel B) (Carl Roth) 
2.5 mL / 2.5 mL Resolving buffer 
3.7 mL / 1.9 mL destilled water 
The above mixture mixed with: 
45 μL 10% Ammonium persulfate (APS)    (Sigma Aldrich) 
5 μL Tetramethylenediamine (TEMED)    (Carl Roth) 
 
Stacking gel (5.6%) (2 Gels)  
0.80 mL Acrylamide (30%) 
0.53 mL Bisacrylamide (2%) 
1.25 mL Stacking buffer 
3.42 mL H2O 
The above mixture mixed with: 
40 μL 10% APS 
10 μL TEMED 
 
Sample buffer (5- fold) 
0.064 M Tris HCl  
1% SDS  
0.01% bromophenol blue      (Sigma Aldrich)  
10% glycerol 
pH 6.8 
 
Running buffer (10-fold) 
25 mM Tris        (Carl Roth) 
0.2 M Glycine 
0.1% SDS 
 
Towbin Blot buffer (1-fold)  
25 mM Tris/HCl       
192 mM Glycin 
200 mL Methanol (100 mL/ 10% buffer)   (AppliChem)  
 
TBS buffer (10-fold) 
0.05 M Tris/HCl 
0.9% NaCl,  
pH 7.5 
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TBS-T (Tris-Buffered Saline-Tween) 
0.5 mL (0.05%) Tween
®
20 
1 L TBS 
pH 7.3-7.4 
 
TBST with Roti
®
block 
9 mL TBST 
1 mL Roti
®
 block  
 
2. Adiponectin cloning buffers   
 
10 x TBE-Buffer 
0,89 M Tris-Base      (AppliChem, Darmstadt, Germany) 
0,89 M Boric acid      (AppliChem) 
0,02 M EDTA (pH 8)      (AppliChem) 
ad 1000 mL ultrapure water, autoclaved  
 
Agarosegel (1 %)  
1X TBE Puffer 
0. 75 g Ultrapure Agarose     Life Technologies GmbH, Darmstadt,  
       Germany)  
30 µl) Ethidium bromide (1 mg/ mL)    (eurobio, France)  
ad 75 mL ultrapure water   
 
Orange G-Loading buffer DNA-Gels (5x Buffer)  
50 mg Orange G      (Chroma Gesellschaft, Münster,Germany) 
2 mL Glycerin  (Carl Roth, Karlsruhe, Germany) 
400 μL EDTA (0,5 M, pH 8,0)  (AppliChem) 
ad 10 mL ultrapure water   
 
Colony PCR 
10 mM dNTPs each      (Thermo Fisher Scientific, Schwerte,  
       Germany)  
20 pmol Stargate Primer Adiponectin, HPLC purified (Sigma Aldrich, St. Luis MO, USA) 
2 U/ µL Fusion™ high fidelity DNA polymerase  (Thermo Fisher Scientific)  
Puffer polymerase fuion buffer  
 µl ultrapure water  
 
Restriction  
HindIII (1 µl/ 1 µg DNA) (10 U/µl)   (Thermo Fisher Scientific)  
XhoI (Er0691) (1 µl/ 1 µg DNA) (10 U/µl) 
Tango buffer 2x  
ad 20µl ultrapure water   
 
3. Adiponectin expression buffer 
 
LB Agar       
40 g Agar      (Carl Roth) 
ad 500 mL 
autoclave   
 
LB medium  
25 g Agar       (Carl Roth) 
ad 1000 mL 
autoclave 
100 mg/L ampicillin  
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LEW buffer 
50 mM monosodium phosphate    (AppliChem) 
NaH2PO4 x H2O      
300 mM sodium chloride    (AppliChem) 
NaCl     
pH 8.0 
 
Elution buffer 
50 mM monosodium phosphate    (AppliChem) 
NaH2PO4 x H2O      
300 mM sodium chloride    (AppliChem) 
NaCl 
500 mM Imidazole     (Carl Roth)    
pH 8.0 
 
Coomassie staining 
2.5 g Brilliant Blue R-250    (Carl Roth) 
450 mL Ethanol     (AppliChem) 
90 mL glacial acetic acid     (Carl Roth) 
ad. 1000 mL 
 
Destaining 
100 mL Methanol 
150 mL glacial acetic acid  
 
4. Immune cell isolation and proliferation test 
 
Freezing medium 
500 mL RPMI 1640 
100 U / 100 mg/ mL Pen/Strep 
40 % FCS 
10 % DMSO      (Carl Roth)  
 
RPMI 1640-S 
500 mL RPMI 1640      (PAA, Austria)  
10 % FCS       (FCS gold, PAA)  
100 U / 100 mg/ mL Pen/Strep    (PAA) 
 
Lysis solution 
0. 01 M HCL       (Carl Roth)  
with 10 % SDS 
 
5. Tissue analyses  
 
Homogenisation buffer 
10 mM HEPES pH 7.4  
complete
®
 protease inhibitor cocktail    (Roche, Mannheim, Germany) 
1 tablet/10 ml buffer       
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Appendix B: Adiponectin sequences 
 
1. Bos taurus adiponectin, C1Q and collagen domain containing (AdipoQ), mRNA Adiponectin se-
quence (NM_174742.2)  
 
CGCCATCGCCTCCTACTTCCACCCTGACTGAAGTCTGTGGCTCTGATTCCACACCTGAGGGGCTCAG
GATGCTGCTGCAGGGAGCTCTTCTACTGCTACTAGCCTTACCCAGTCATGGCGAGGACAACATGG
AAGATCCCCCGCTGCCCAAGGGGGCCTGCGCAGGTTGGATGGCAGGCATCCCAGGACATCC
TGGCCACAATGGCACACCAGGCCGTGATGGCAGAGATGGCACTCCTGGAGAGAAGGGAGAG
AAAGGAGATGCAGGTCTTCTTGGTCCTAAGGGTGAGACAGGAGATGTTGGAATGACAGGAGC
TGAAGGGCCACGGGGCTTCCCCGGAACCCCTGGCAGGAAAGGAGAGCCTGGAGAAGCCGCT
TATGTGTATCGCTCAGCGTTCAGTGTGGGGCTGGAGACCCGCGTCACTGTTCCCAATGTACC
CATTCGCTTTACTAAGATCTTCTACAACCAACAGAATCATTATGACGGCAGCACTGGCAAGTT
CTACTGCAACATTCCGGGACTCTACTACTTCTCTTACCACATCACGGTGTACATGAAAGATGT
GAAGGTGAGCCTCTTCAAGAAGGACAAGGCCGTTCTCTTCACCTACGACCAGTATCAGGAAA
AGAATGTGGACCAGGCCTCTGGCTCTGTGCTCCTCCATCTGGAGGTGGGAGACCAAGTCTGG
CTCCAGGTGTACGAGGGTGAAAATCACAATGGGGTCTATGCAGATAATGTCAATGACTCCAC
CTTCACAGGCTTCCTTCTCTACCATAACATTGTTGAATGAATGAGCACCATTAACTCAGAGTCTC
CATTGGGCCAAGCAGCACAAAGTGAAAGAACTACATTGTAGTTAGGAGACCAATTTTATTATCTAG
CTGAGGGGATTCTGAACATCATTCATTTATTCATTCATCAAGTACCTTTTTTAAGAAATGATATACC
ATGTTCCCAGGACAGTCTTGAAGAAGACATGTCCCCTGGCCTCAAGGATCTGTTGTGTAGTGGTAA
TGGAAGGATGATAACATTTACTGGGGAGTTTCATATACATGACAAGATAACTAACTACAAGAAAGT
ATTTGACAGTGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
 
The grey part is the signalsequence and the bold one the translated adiponectin nucleotides. In total 
adiponectin has a size of 669 bp.  
 
2. Amino acid sequence of translated adiponectin:  
5'3' Frame  
E D N Met E D P P L P K G A C A G W Met A G I P G H P G H N G T P G R D G R D G T P G E K G E K G 
D A G L L G P K G E T G D V G Met T G A E G P R G F P G T P G R K G E P G E A A Y V Y R S A F S V 
G L E T R V T V P N V P I R F T K I F Y N Q Q N H Y D G S T G K F Y C N I P G L Y Y F S Y H I T V Y 
Met K D V K V S L F K K D K A V L F T Y D Q Y Q E K N V D Q A S G S V L L H L E V G D Q V W L Q 
V Y E G E N H N G V Y A D N V N D S T F T G F L L Y H N I V E 
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3. Sequences of the entry vector with the AdipoQ insert 
 
ATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGC
GTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCA
GAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCG
CTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTG
TGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGATTCCAACCC
GGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATG
TAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTG
GTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAAC
AAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGAT
CTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAG
GGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCGAGCTTCAGAAGAACTCGTCAAGAAGGC
GATAGAAGGCGATGCGCTGCGAATCGGGAGCGGCGATACCGTAAAGCACGAGGAAGCGGTCAGCC
CATTCGCCGCCAAGCTCCTCAGCAATATCACGGGTAGCCAACGCTATGTCCTGATAGCGGTCCGCC
ACACCCAGCCGGCCACAGTCGATGAATCCAGAAAAGCGGCCATTTTCCACCATGATATTCGGCAAG
CAGGCATCGCCATGGGTCACGACGAGATCCTCGCCGTCGGGCATGCTCGCCTTGAGCCTGGCGAAC
AGTTCGGCTGGCGCGAGCCCCTGATGTTCTTCGTCCAGATCATCCTGATCGACAAGACCGGCTTCC
ATCCGAGTACGTGCTCGCTCGATGCGATGTTTCGCTTGGTGGTCGAATGGGCAGGTAGCCGGATCA
AGCGTATGCAGCCGCCGCATTGCATCAGCCATGATGGATACTTTCTCGGCAGGAGCAAGGTGAGAT
GACAGGAGATCCTGCCCCGGCACTTCGCCCAATAGCAGCCAGTCCCTTCCCGCTTCAGTGACAACG
TCGAGCACAGCTGCGCAAGGAACGCCCGTCGTGGCCAGCCACGATAGCCGCGCTGCCTCGTCTTGC
AGTTCATTCAGGGCACCGGACAGGTCGGTCTTGACAAAAAGAACCGGGCGCCCCTGCGCTGACAG
CCGGAACACGGCGGCATCAGAGCAGCCGATTGTCTGTTGTGCCCAGTCATAGCCGAATAGCCTCTC
CACCCAAGCGGCCGGAGAACCTGCGTGCAATCCATCTTGTTCAATCATGCGAAACGATCCTCGAAG
CATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAAT
AGGGGTTCCGCGCACATTTCCCCGAAAAGTGCTGGACCCATCTAGCAACCCCTTGGGGCCTCTAAA
CGGGTCTTGAGGGGTTTTTTCTAGAAAAGCGCGTCTCCAATGATTGAGGGTCGCGAGGACAACA
TGGAAGATCCCCCGCTGCCCAAGGGGGCCTGCGCAGGTTGGATGGCAGGCATCCCAGGACA
TCCTGGCCACAATGGCACACCAGGCCGTGATGGCAGAGATGGCACTCCTGGAGAGAAGGGA
GAGAAAGGAGATGCAGGTCTTCTTGGTCCTAAGGGTGAGACAGGAGATGTTGGAATGACAG
GAGCTGAAGGGCCACGGGGCTTCCCCGGAACCCCTGGCAGGAAAGGAGAGCCTGGAGAAGC
CGCTTATGTGTATCGCTCAGCGTTCAGTGTGGGGCTGGAGACCCGCGTCACTGTTCCCAATG
TACCCATTCGCTTTACTAAGATCTTCTACAACCAACAGAATCATTATGACGGCAGCACTGGCA
AGTTCTACTGCAACATTCCGGGACTCTACTACTTCTCTTACCACATCACGGTGTACATGAAAG
ATGTGAAGGTGAGCCTCTTCAAGAAGGACAAGGCCGTTCTCTTCACCTACGACCAGTATCAG
GAAAAGAATGTGGACCAGGCCTCTGGCTCTGTGCTCCTCCATCTGGAGGTGGGAGACCAAGT
CTGGCTCCAGGTGTACGAGGGTGAAAATCACAATGGGGTCTATGCAGATAATGTCAATGACT
CCACCTTCACAGGCTTCCTTCTCTACCATAACATTGTTGAAGGGAGGAGACGCGCTAAAAGCTT
AAAAAAAATGTCGCACAATGTGCGCCATTTTTGTCGAGGGCAATCCAAAGGCGGTAATACGGTTAT
CCACAGAATCAGGGG 
 
Total size 2451 bp. Adiponectin nucelotides are bold (669 bp), the cleavage sites for Hind III und Xba 
I are highlighted in grey and the cleaveage site for factor Xa (12 bp) is underlined. 
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